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ABSTRACT(
There is a lack of studies demonstrating positive effects on glycaemic control and HRQoL in 
children and adolescents starting CSII treatment. Guidelines recommend measuring perceived 
HRQoL routinely. It is important to have questionnaires, not overly comprehensive or time-
consuming, to measure HRQoL in children and adolescents as well as their parents. 
Structured and person-centred education has been emphasized as a key to successful self-
management. Guided Self-Determination-Young (GSD-Y) is a person-centred 
communication and reflection method. The overall aim of this thesis was to increase the 
knowledge regarding glycaemic control, type of treatment, HRQoL, and a theory-based 
education among youth with type 1 diabetes. 
Study I was a retrospective case-control study comparing children and adolescents starting 
CSII (n=216), with a control group treated with MDI (n=215). Children and adolescents who 
had started CSII showed improvement in glycaemic control, measured as HbA1c, during the 
first six months. For boys, this improvement could be identified throughout the first year.  
In Study II, 197 parents and their children with type 1 diabetes completed the proxy and 
child versions of the questionnaires Check your Health and DISABKIDS to test the 
psychometric properties of Check your Health by proxy. The test of the reliability and 
validity of this questionnaire showed acceptable psychometric properties. 
Study III, an RCT evaluating a GSD-Y education, included 71 adolescents starting CSII and 
their parents. The intervention group (n=37) attended seven group education sessions, lasting 
for about two hours each, using the GSD-Y method. The participants were followed for six 
months. The GSD-Y method showed a positive effect on glycaemic control, especially for 
participants with an HbA1c above 63 mmol/mol (n=48) at inclusion (p= 0.037); furthermore, 
readiness to change increased (p=0.037). A correlation was identified between HbA1c and 
goal achievement (rs=-0.475, p=0.001), and readiness to change (rs=-0.487, p=0.001). In 
Study IV, 13 adolescents were interviewed after the intervention with GSD-Y. From the 
qualitative analysis, two categories emerged: the importance of context, and growing in 
power through the group process. An overarching theme that emerged from the interviews 
was the importance of expert and referent power in growing awareness of the importance of 
self-management, as well as mitigating the loneliness of diabetes. Further, the findings 
showed that it is valuable for adolescents to meet other young people in the same situation, 
and to share their experiences from living with diabetes. 
In conclusion the four studies showed, treatment with CSII may initially result in improved 
HbA1c. Group education with the GSD-Y method, for adolescents and their parents, has the 
potential to further improve HbA1c, mitigate the loneliness of diabetes, and contribute to 
conscious reflection about self-management. The Check your Health questionnaire by proxy 
has shown acceptable psychometric characteristics, and may be useful in both studies and 
clinical settings.  
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1( PREFACE(
 
I remember when I was new, as a nurse, at the children’s diabetes outpatient department at 
Huddinge Hospital. When a patient – usually an adolescent – had unsatisfactory HbA1c (90-
130 mmol/mol), the routine was that they were booked for frequent visits to the diabetes 
nurse, between their physician visits. What was I supposed to do? Check their HbA1c, of 
course, but what else? There was no possibility to download data from blood glucose meters 
or insulin pumps. I had limited and insufficient diabetes knowledge and skills, and further, 
perhaps most importantly, no knowledge in different communication methods. It was 
incredibly frustrating to meet these, usually very nice, teens and have nothing to offer them. 
I have worked as a nurse since 1989. During my first years, I worked with premature children 
and children at the intensive care department. As a coincidence, I started working at the 
endocrinology outpatient department for children and adolescents at Huddinge Hospital. The 
diabetes nurse was my colleague, but diabetes seemed far too difficult and complicated for 
me. Just next to my workplace was the paediatric ward, which became my next workplace. 
There, I had to take care of children who were newly diagnosed with diabetes; it was at this 
point that my interest in this patient group was awakened, especially thanks to Dr Torun 
Torbjörnsdotter. 
Working on wards with a great deal of technology, it was natural that I became interested in 
the technical aspects of diabetes care, insulin pumps, and continuous glucose monitoring 
(CGM). With great cooperation and much support from Dr Eva Örtqvist (who also 
introduced me to research), I had the opportunity to structure the insulin pump starts at the 
diabetes outpatient department at Astrid Lindgren Children's Hospital, and for this I received 
the Karoline Prize at Karolinska University Hospital. 
Through my work, I met my supervisors Anna Lindholm Olinder and Gunnel Viklund, who 
led me into what this dissertation is about. Both, in different ways, had concluded in their 
dissertations that there was a need for improved education for adolescents and that this had to 
be done together with their parents. This fact, along with my interest in insulin pumps, was a 
natural step toward this dissertation addressing education and children and adolescents 
starting to use an insulin pump. 
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2( INTRODUCTION(
 
In 2015 it was estimated that 542,100 children worldwide were living with type 1 diabetes 
and a further 86,000 children developed the disease annually, with Europe having the highest 
prevalence (1). In Sweden there are 7,310 children and adolescents living with type 1 
diabetes; this prevalence has been stable since 2008. Treatment consists of either multiple 
daily injections of insulin (MDI) or continuous subcutaneous insulin infusion (CSII) (2); 
today, CSII is the most physiological way to deliver insulin (3, 4). In 2016, 60.9% of children 
and adolescents with type 1 diabetes in Sweden were treated with CSII (2), and in Europe this 
figure was 45.8% (5). 
According to the International Society for Pediatric and Adolescent Diabetes (ISPAD) and 
International Diabetes Federation (IDF) Guidelines, the recommended glycaemic control, 
measured with HbA1c, for children and adolescents is <58 mmol/mol without an increase in 
the number of hypoglycaemic episodes (6, 7). The Swedish guideline for HbA1c has been 
lowered to 48 mmol/mol, which is consistent with recommendations from the National 
Institute for Care Excellence (NICE) in the UK (8, 9).  
The Diabetes Control and Complications Trial (DCCT) and follow-up data clearly indicate 
that poor glycaemic control during adolescence and young adulthood increases the risks of 
micro- and macrovascular complications later in life (10, 11). In the same manner, 30 years 
after the DCCT study, the Epidemiology of Diabetes Interventions and Complications 
(EDIC) study showed that intensive diabetes treatment decreases the incidence of 
cardiovascular disease (12).  
ISPAD recommends routinely measuring perceived Health-Related Quality of Life (HRQoL) 
(13). At the same time, it should be noted that there are few questionnaires available for doing 
so for children and adolescents in Swedish (14-16). 
ISPAD emphasizes that education is the key to successful self-management. Adolescents 
have the right to receive a structured, person-centred and flexible education, which may 
strengthen them and their parents in taking control of their diabetes self-management (17). 
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3( BACKGROUND(
 
3.1( THE(HISTORY(OF(ILLNESS,(DIABETES(AND(DIABETES(EDUCATION(
In the eighteenth century, the patient’s experiences of living with an illness played a 
secondary role. The classification of disease shifted from being based on symptoms 
experienced and described by the patient to organic damage present in the dead body. The 
real disease could best be explored in the dead body. This view of the body stimulated a 
dramatic technological development. During the nineteenth century, technological advances 
such as the stethoscope and x-ray offered opportunities to ‘anatomize’ the living body. It is 
notable that modern medicine is mainly based not on the lived body, but rather the dead one 
(18). 
In some situations, the patient is still treated as almost dead, for example at a physical 
examination when he/she is asked to lie down, silent and nearly naked, on a couch. This ritual 
might reduce the living body to something almost dead. However, it seems that there is 
gradually arising a quest for healthcare personnel to acquire a holistic view of human beings.  
The philosopher Maurice Merleau-Ponty (1908-1961), along with other philosophers, coined 
the term ‘the lived body’ in reference to living bodies. The body is a unit, towards and with a 
perceived world, living together in relationships with other people, things, and the 
environment. Merleau-Ponty describes the lived body as intertwined – thinking and 
materiality are not separated (18). In meetings with young people with chronic illness such as 
diabetes, it is important not to treat them like a machine that works the same way as other 
machines. They are a ‘lived body’, everything in life is intertwined, and if you ask them for 
their story, you will hear about a part of the world in the way they embody it. 
One way to describe and understand illness is that one feels un-homelike being-in-the-world. 
Here, un-homelike is the opposite of the normal meaning of healthy being-in-the-world, 
homelike. Living in our own bodies with illness is perceived as un-homelike. My body is 
experienced as an alien, but at the same time as myself, with biological processes that I, 
myself, have no control over. These are lived by me and belong to me. Merleau-Ponty 
describes how the body ‘understands’ and ‘inhabits’ the world. The body is not only a tool or 
a dwelling I live in; it is me. When illness has caused a sense of un-homelikeness, a person 
needs to be guided as far as possible in order to regain the feeling of homelikeness. The 
degree to which this is possible depends on healthcare professionals, family and friends, but 
mostly and finally, it depends on the person him/herself. It is possible to regain homelike 
being-in-the-body and being-in-the-world in dialogue with others, but it must happen in that 
person’s own way (19). Adolescence is a period of development physically and mentally, 
which could mean that even a person without a chronic illness might not feel homelike in 
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his/her own body; thus, for adolescents with type 1 diabetes or any other illness, a feeling of 
un-homelikeness can arise in a double sense. Against this background, it is easier to 
understand when adolescents with type 1 diabetes express that they feel different, vulnerable 
and alone (20-23). 
The period 1914-1936 is crucial in the history of diabetes nursing and education. During this 
period, most nurses had little or no education. In 1913, Dr Frederick Allen became the first to 
present a treatment that prolonged the life of persons with diabetes, in ‘Studies concerning 
Glucosuria and Diabetes’. The treatment was a diet commonly called starvation therapy, for 
minimizing the risk of acidosis and uraemia. Dr Elliot P Joslin (1869-1962), one of the first 
diabetologists, working closely with the New England Deconess Hospital School of Nursing 
in Massachusetts in the US, was a pioneer in several ways. He introduced the starvation 
therapy in practice, and the overall goal was to educate persons with diabetes to be able to 
manage themselves. He wanted, with the help of educated nurses, to empower patients to take 
care of their own diabetes. However, at the time nurses normally had little or no training, and 
he stressed the importance of educating them. In 1917, he stated that a diabetes-nursing 
specialty could be a new career for nurses and that ‘a well-educated nurse was of more 
importance than the patient’s doctor’ (24).   
In 1921, Frederick Banting and Charles Best discovered insulin. However, they worked in 
collaboration with Dr John James Rickard Macleod who had a medical laboratory. He was 
also the one who supported them, and presented their findings to the world. Furthermore, it 
was Frederick Banting and Dr Macleod who were awarded the Nobel Prize (24). 
Dr Joslin and his nurses conducted the first trials regarding insulin treatment, and he 
developed an education programme to teach patients to inject insulin. On August 6, 1922, Dr 
Joslin and his co-workers administered the first injection to a 42-year-old nurse. After the 
discovery of insulin, most patients with diabetes were treated in outpatient clinics. In 1927, 
Dr Joslin initiated ‘the wandering diabetes nurse’ who should be ready to go wherever the 
diabetes patients needed her. Her task was to support parents after returning home from the 
hospital in achieving adequate self-care, e.g. learning to inject insulin and calculate 
carbohydrates, as well as test urine glucose and interpret the values; furthermore, she visited 
schools and provided diabetes camp instructions (24).  
Even during the first years of insulin use, nurses continued to publish articles on the 
starvation diet; it was not until 1929 that the first article on insulin and nursing care was 
published. By 1936 the nursing care had developed into a diabetes-nursing specialty, with 
educators teaching patients to inject insulin, count carbohydrates, and measure urine glucose. 
Iris Langhart published the first article describing the diabetes education model and the 
diabetes nurse educator. She described individualized education, the objective of the 
education, the value of teaching in teams, and an effective education model (24).  
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3.2( DIABETES(
For a person with type 1 diabetes it is a constant struggle – a lifelong project – to perform 
optimal self-management, have acceptable glycaemic control, have a good life, be able to do 
what you want and, in the short and long term, avoid complications. In everyday life, this 
includes assessing insulin doses, adjusting them if needed, and ‘continuously’ having control 
over your glucose level (25). 
Glycosylated hemoglobin A1c (HbA1c) measures glycemic control, and seems to reflect an 
average of the previous two to three months (26-28). The normal reference for children 
between six months and 18 years is 31-38.6 mmol/mol (5-5.7 DCCT %) (29).  
In Sweden, the mean value for HbA1c has decreased in recent years in all paediatric age 
groups; in 2016 it was 56.9 mmol/mol. Among children and adolescents with type 1 diabetes 
there are clear age- and gender-related differences. After starting school (at 7 years of age) 
HbA1c tends to increase, and girls have more unsatisfactory glycaemic control than boys (2). 
Data from the Swedish National Diabetes Register SWEDIABKIDS showed that girls had 
higher HbA1c at diagnosis than boys, and that those who had HbA1c >78 mmol/mol during a 
specific period (2007) had remaining high HbA1c three years later (30). Moreover, among 
young adults, data from SWEDIABKIDS and NDR have shown a higher incidence of 
retinopathy among women compared with men (31). 
The risk for a person with type 1 diabetes dying from any cause, including cardiovascular 
disease, is twice for well-controlled patients (HbA1c <52) than that of a matched control 
group without diabetes, and increases with increased HbA1c (32). Furthermore, there is a risk 
for short-term complications such as hypoglycaemia and ketoacidosis, of which 
hypoglycaemia is the most common. The accepted definition of hypoglycaemia is a glucose 
value <3.6 mmol/l; however, in clinical practice a glucose value of <4 mmol/l is the 
recommended level to be treated. Hypoglycaemic events may be symptomatic or 
asymptomatic, and as these affect everyday life they may be barriers to achieving optimal 
glycaemic control (33). Ketoacidosis may be caused by a frequent absence of insulin doses, 
poor glycaemic control, previous episodes of ketoacidosis, and failure in CSII treatment. 
Unless this condition is corrected it is fatal; therefore, it is important to educate patients and 
their families about symptoms and in how to correct insulin deficiency (34).  
3.2.1( Self8management(and(self8care(
There are several definitions of ‘self-management’ and ‘self-care’ moreover, these concepts 
are widely used synonymously (35). The term reported in the following studies is the one 
used by the authors. Based on an analysis of 99 references, Schilling et al. suggested the 
following definition of self-management of diabetes in children and adolescents with type 1 
diabetes: ‘Self-management of type 1 diabetes in children and adolescents is an active, daily, 
and flexible process in which youth and their parents share responsibility and decision-
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making for achieving disease control, health, and well-being through a wide range of illness-
related activities’ (36, p. 92).  
Pelicand et al. performed a review including 30 articles, with the objective of evaluating how 
‘self-care’ is used in education interventions in patients with type 1 diabetes. Mostly, self-
care is defined a series of disease-related actions, and these actions are mostly related to 
physical health. In children and adolescents, these are carried out individually or with help 
from their caregiver. When autonomy is included, this usually relates to the level necessary 
for performing daily technical self-care activities. It is rarely used with clear reference to 
psychosocial aspects. Furthermore, it is rarely used alone, but rather along with other terms 
like self-care behaviour, self-care management, or self-care activities (self-care activities are 
usually medical). Pelicand et al. have highlighted that the factors that most affect self-care in 
the family are cognitive and psychosocial. Cognitive factors include, notably, parents’ level 
of knowledge and awareness as predictors of their ability to support self-care activities for 
their children. Psychosocial factors in the family, likely to affect self-care support for 
adolescents, are: family function, family stress, the occurrence of conflicts, how the youth 
and parent communicate, and type of parent support (35). 
‘Assuming responsibility for self-care’ has been clarified through concept analyses by Hanna 
et al. and defined as ‘a process specific to diabetes within the context of development. It is 
daily, gradual, individualized to person, and unique to task. The goal is ownership that 
involves autonomy in behaviours and decision-making’ (37, p. 104).  
3.2.2( Patient8reported(outcomes((PROs)(
Patient-Reported Outcomes (PROs) provide patients’ perspectives on treatment beyond 
medical parameters, which are often important to patients. This includes patients’ experiences 
of their own health, QoL, or abilities associated with their current treatment or with the 
healthcare system. Patient-Reported Outcome Measures (PROMs) are included in PROs, and 
are measurements and/or tools used to report the PROs. The most common dimensions are 
general QoL and HRQoL, which have become increasingly important for capturing patients’ 
feelings and experiences (38).  
Aristoteles (384-322 BC) was one of the first to attempt to define QoL. He described that 
every person imagines ‘the good life’ or ‘doing well’ as equivalent to ‘being happy’. 
However, some have expressed that a more correct description of the Greek word would be 
‘well-being’, which Aristoteles denoted as both a feeling and a kind of activity. He stated 
(which is also relevant to discussions today) that QoL means different things to different 
people and that it varies depending on a person’s current situation. Since then, QoL has been 
mentioned very rarely before the twentieth century (39). WHO defines QoL as ‘an 
individual’s perception of their position in life in the context of the culture and value systems 
in which they live, and in relation to their goals, expectations, standards and concerns’ (40, p. 
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361). However, there are several other definitions of QoL, often emphasizing components of 
happiness and satisfaction with life. HRQoL is used to distinguish between more general QoL 
and its use when related to clinical medicine or clinical trials (39). However, the definition by 
the Food and Drug Administration (FDA) is: ‘HRQoL is a multi-domain concept that 
represents the patient’s overall perception of the effect of an illness and its treatment on 
physical, psychological and social aspects of life’ (41, paragraph. 5.5).  
The National Diabetes Register (NDR) of Sweden acts as a tool in clinical work, quality 
improvement, the assessment of diabetes care, and epidemiological research. As a first step 
the NDR has developed a new diabetes-specific PROM, and evidence has been established 
for face and content validity (42, 43).  
For adolescents, there are no differences in HRQoL between those with diabetes and those 
without it. On the other hand, girls both with and without diabetes report poorer quality of 
life than boys do (44, 45). 
HRQoL factors for adolescents with type 1 diabetes are associated with glycaemic control. 
(45, 46). Adolescents with unsatisfying glycaemic control have lower physical and mental 
health, and experience a higher burden of diabetes and lower empowerment (46).  
Results from a study including adolescents and their parents indicate that fewer diabetes-
specific family conflicts are associated with better psychosocial wellbeing and less depressive 
symptoms. Poorer glycaemic control is associated with living with a single parent, being a 
member of an ethnic minority, and lower wellbeing (47). Likewise, lower HRQoL is 
associated with diabetes-related conflicts and negative diabetes-related family 
communication. Further, higher levels of HRQoL are associated with collaborative parent 
involvement in diabetes care (48). Similarly, a study involving children and adolescents (aged 
8-17 years) shows that diabetes-specific family conflicts are the only predictor of total QoL 
(49).  
However, family structure, conflicts, and children’s moods are some factors that influence 
glycaemic control. The Risk Index for Poor Glycaemic Control (RI-PGC), a measure for 
predicting deteriorated glycaemic control, can be used by physicians and nurses. 
Unfortunately, it has not yet been translated into the Swedish language or validated (50). 
For children and adolescents there are nine questionnaires measuring HRQoL, of which five 
are diabetes-specific (51). DISABKIDS Chronic Generic Module-37 (DCGM-37), including 
the diabetes-specific module (DSM-10) (14), and PedsQL (15) have been translated into 
Swedish and psychometrically tested. Both have a generic and a diabetes-specific part, 
totalling 50 and 51 items, respectively. For both questionnaires, there is a proxy version for 
parents (14, 15). The DCGM-37 and DSM-10 have been developed and pilot- and field-tested 
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with seven European countries (including Sweden) involved, which strengthens the 
questionnaire’s cross-cultural validity (52-54).  
Since a questionnaire’s response rate is reduced when it is comprehensive and time-
consuming to complete (55), Wikblad et al. developed the questionnaire Check your Health. 
It consists of four pages with one domain/item on each page, and measures perceived health, 
relationships, QoL, and burden of diabetes; the unique aspect of this instrument is that, while 
it is not comprehensive or time-consuming, it still measures these items (55, 56). Its 
psychometric properties have been tested for adults and adolescents (16, 56).  
3.2.3( Insulin(pump(treatment(and(continuous(glucose(monitoring((CGM)(
Insulin pump treatment - continuous subcutaneous insulin infusion (CSII) 
CSII was introduced 35 years ago in order to achieve long periods of near-normal glucose 
values in patients with type 1 diabetes (57, 58). The basal rate is automatically infused by the 
insulin pump in a pre-programmed pattern. For carbohydrate meals or when glucose levels 
are above the target, a bolus dose can be delivered manually (4). The Swedish national 
guidelines for initiating CSII treatment for children and adolescents are broad (59). However, 
treatment with CSII is associated with increased costs compared with MDI (60). Some 
studies have shown that CSII is cost-effective when it results in improved glycaemic control 
and Quality of Life (QoL) (61-63). These studies presume a greater effect on glycaemic 
control and/or reduced number of hypoglycaemic events when treated with CSII than is 
shown in recent studies (60). In Sweden, boys treated with CSII have a slightly higher HbA1c 
(0.6 mmol/mol) than boys treated with MDI, while there is no difference among girls (42). 
On the other hand, children and adolescents with type 1 diabetes in Europe have a higher 
HbA1c when treated with MDI, compared with those on CSII (5). 
There are recently published studies showing positive effects of CSII on diabetes-related 
complications. A unique Swedish study with data from NDR included 18,168 persons with 
type 1 diabetes, of whom 2,441 were treated with CSII and 15,727 with MDI. All had been 
diagnosed with type 1 diabetes before the age of 30. The follow-up was at 6.8 years, and has 
shown that the adjusted hazard ratios were significantly lower for participants treated with 
CSII than for those treated with MDI: 0.58 for fatal cardiovascular disease (coronary heart 
disease or stroke) and 0.73 for all-cause mortality (64).  
Furthermore, the incidence of microvascular complications was investigated, comparing CSII 
and MDI in an Australian study including 989 patients (12-20 years) with a diabetes duration 
of more than five years. There was no difference in HbA1c between patients treated with 
CSII (70 mmol/mol) and MDI (72 mmol/mol) (p= 0.7). However, CSII treatment was 
associated with a lower risk for retinopathy (OR 0.66, 95% CI 0.45–0.95, p=0.029) and 
peripheral neuropathy (OR 0.63, 95% CI 0.42–0.95, p=0.026) (65). 
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A report by the Swedish Agency for Health Technology Assessment and Assessment of 
Social Services (SBU) showed that there is a great lack of knowledge about the effects of 
CSII treatment compared with MDI for children and adolescents. The report’s inclusion 
criteria were: studies involving an intervention with participants using CSII with analogue 
insulin and a control group on MDI using analogue insulin for meals. Exclusion criteria were 
intravenous insulin treatment and intraperitoneal insulin treatment. Additionally studies 
needed to have more than ten participants in each arm, and should be a randomized controlled 
trial (RCT) or clinical controlled trial (CCT) with a follow-up time of more than three 
months. Eleven articles were found that fulfilled the criteria for inclusion. However, only two 
studies with moderate or high quality included children and adolescents (60), and they had 
been newly diagnosed with type 1 diabetes (66, 67).  
One of the studies included in the above report, a Swedish RCT study by Skogsberg et al., 
included a total of 72 children and adolescents (aged 7-17 years), randomized to CSII or MDI 
and they were followed for 24 months. There were no differences in glycaemic control 
between the treatment groups, but treatment satisfaction was higher in the CSII group (66). 
The second study was an RCT pilot trial comparing CSII with MDI treatment in 24 
participants (aged 8-18 years). Five participants withdrew during the study period, which 
meant that by the end of the study only 19 participants remained. At six months an 
improvement was identified in the CSII group, but it was not significant (p=0.06), and at 12 
months there was no difference (67).  
Using less strict approaches, there are several studies that have reported results that could be 
informative. Table 1 presents those published in approximately the past ten years (68-72).  
Among adolescents treated with CSII, one explanation for deteriorated glycaemic control is 
omitted bolus doses before meals (73, 74). This is mainly explained by loss of focus, as 
children and adolescents sometimes forget to take their meal doses (75). 
Results from a Danish study including children treated with CSII (n=296) and MDI (n=404) 
showed that those on CSII and with a diabetes duration of more than one year reported better 
HRQoL, especially regarding generic HRQoL (76), which is consistent with results in the 
study by Lukacs et al. (44). On the other hand, a Norwegian study showed no differences on 
HRQoL between children and adolescents treated with CSII (n=503) and MDI (n=434). 
However, lower scores on HRQoL were associated with poorer glycaemic control and being 
a girl (77). 
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Table 1. Studies comparing CSII treatment and MDI treatment. 
Authors 
(publ year) 
Design Age 
(years) 
Partici-
pants (n) 
Dur of 
study 
(months) 
Result HbA1c   Treatment 
     CSII vs. MDI 0 vs.12 months  
p-value (difference 
in mmol/mol) 
0 vs. end of study  
p-value (difference 
in mmol/mol) 
 
Schiaffini et 
al. (2007) * 
(71) 
RCT 9-18 CSII: 18 
MDI: 18 
24   CSII: NS,  
MDI: p<0.05 (-8.7) 
CSII: <0.05 (-7.6) 
MDI: NS 
CSII: Rapid-acting analogue 
insulin  
MDI: Glargine and human 
regular insulin  
Jakisch et al. 
(2008) (69) 
Case-control 
(register 
study) 
8-14  CSII: 434 
MDI: 434 
36  12 months: p= 0.006 
24 and 36 months: 
NS 
  Type of insulin not mentioned  
Johannesen 
et al. (2008) 
(70) 
Case-control 13-19 CSII: 30 
MDI: 26 
12  CSII: NS 
MDI: NS 
 CSII: Actrapid 
MDI: Actrapid and NPH  
Johnson et al. 
(2013) (72) 
Case-control 11.5 + 
3.7 
CSII: 355 
MDI: 355 
60 12, 36, 48 and 60 
months: p<0.05 
CSII: p<0.05 
MDI: NS 
CSII: p<0.05 (-7.7) 
MDI: (+17.1) 
CSII: Type of insulin not 
mentioned 
MDI: 37% Glargine, 63% 
NPH and human regular 
insulin 
Fendler et al. 
(2012) (68) 
Observational 10.8–
16.2 
 
CSII: 223 
MDI: 231 
36.6 + 
16.8 
(mean) 
End of study: 
p=0.002 
 MDI: NS 
CSII: NS 
 
CSII: 81% Analog, 19% 
Human insulin 
MDI: Long-acting analogues 
or NPH, short-acting 
analogues or human regular 
insulin 
* Inclusion criteria HbA1c > 64 mmol/mol (8 DCCT %) 
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Technical devices  
In recent years, the use of CGM and SAP (sensor-augmented pump therapy) has increased. In 
an RCT study including adults and children (age groups >25 years, 15-24 years, and 8-14 
years), 165 of the participants were assigned to CGM and 157 to the control group. The 
duration of the study was 26 weeks. In the two groups including children and adolescents, 
there were no differences in glycaemic control between the group assigned to CGM and the 
one that was not. However, the proportion who used CGM for six days or more for a week 
was considerably lower among the children and adolescents compared with the adults (>25 
years 85%, 15-24 years 30%, and 8-14 years 50%) (78). Furthermore, Bergenstal et al. 
included 485 patients aged 7-70 years (156 children aged 7-18 years) in an RCT study. Of 
these, 166 adults and 78 children were assigned to SAP and the control group continued with 
MDI. After 12 months, the children in the SAP group had decreased their HbA1c while the 
MDI group had increased slightly (p<0.001) (79).  
Positive results have been shown when CGM is added to CSII treatment. HbA1c and time 
spent in hypoglycaemia decreased during the CGM period. Moreover, the amount of 
mealtime boluses increased when using CGM. For those who used CGM less than 70% of the 
time, the decrease in HbA1c was smaller (80). Furthermore, a recent review of CGM in 
children and adolescents concluded that CGM is safe and effective in this age group (81). 
Parents of children and adolescents (1-17 years) reported that CSII was beneficial to both 
them and their children, while, CGM was of more advantage to the parents than to their 
children. Furthermore, the parents described that it was easier to reach the targets for glucose 
values with the help of technology (82). On the other hand, children and adolescents using 
SAP do not report better HRQoL; however, they do report better treatment satisfaction (83, 
84). 
For a few years, Flash Glucose Monitoring (FGM) has been available as an alternative to 
measuring glucose control by finger stick or with CGM. A small sensor is worn on the back 
of the arm. A scanner, which displays glucose values after scanning over the sensor, does not 
need to be close to the sensor, and are factory calibrated (do not require calibration). The 
scanner has no automatic alarms, but during scanning shows trend arrows, current glucose 
value, and eight-hour glucose history. In Sweden, FreeStyle Libre, an FGM system, became 
available to adults in 2014 and to children and adolescents in 2016. For children and 
adolescents, FGM has shown to be accurate, safe and user-friendly (85). A study involving 
adult patients showed a decrease in the time spent in hypoglycaemia for those using FGM, 
compared with the control group using self-monitoring of blood glucose (86). 
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3.3# LIFE#WITH#DIABETES#
3.3.1# Adolescence#and#diabetes#
The way to adulthood is long, and fraught with many temptations and risks. Everyone must 
experiment to find their own way, trying different lifestyles to find their personality. The 
experiments involve success and mistakes, which lead to learning and development. This era 
is necessary in order to become an independent individual, to rely on oneself, and develop 
one’s own identity. During this period, the adolescent has to develop a new relationship with 
his/her parents, be able to have close relationships with individuals outside the family, 
consider how to live life as an adult, develop a lifestyle and self-care, and plan a career. 
Simply put, adolescents need to learn to take care of themselves and their lives. Gradually, 
the cognitive ability to analyse and the imagination will be developed, both of importance in 
the development of one’s identity (87, 88).  
Adolescents have described constantly struggling with their diabetes self-management, 
dealing with hypoglycaemia and hyperglycaemia, as well as with the fear of complications 
later in life. They describe a fear of nocturnal hypoglycaemia, as well as anxiety about falling 
asleep and the risk of dying in their sleep. They are aware of diabetes as a chronic illness that 
will last forever; they have to live their life in a new way – a life with type 1 diabetes (25). A 
study has identified five trajectories of glycaemic control: ‘stable on target, stable above 
target, volatile late peak, stable high, and inverted U’. Parents’ social status and family 
structure differed in those groups with unsatisfied poor or divergent glycaemic control from 
the ‘stable on target’ group. Additional factors that distinguished the ‘stable on target’ group 
from the one with unsatisfactory glycaemic control were conflicts with friends, the quality of 
the communication, psychological distress, and self-care behaviour at study start (89, p. 5-7). 
In the same manner, a cross-sectional multicentre study has shown that factors shown to 
associate with satisfactory glucose control were high socioeconomic status, parents’ 
educational level, usage of carbohydrate counting, usage of CSII continuously or for shorter 
periods, and BMI within the normal range. In a logistic regression analysis, the factors that 
could be demonstrated to be of significance for glycaemic control were socioeconomic status 
and years of education for the mother (90).  
3.3.2# Transition#of#responsibility##
Glycaemic control is worse during adolescence than during childhood (2). Children and 
adolescents with diabetes and their parents describe, in varying ways, that they want to be 
like everyone else (20-23, 25, 91). One stressor described by adolescents is worries about 
ineffective self-management during the period when taking over the responsibility (92). Low 
blood glucose values and self-care activities, including blood glucose tests and insulin 
administration, are described as challenging for adolescents (22). Parental involvement and 
shared diabetes self-management have shown to be important during adolescence (88, 93-96). 
In an interview study, young adults (20-22 years) in Sweden describe the importance of their 
parents, especially their mothers, during this period of crucial change (97). 
   13 
Regarding adolescents’ and their parents’ experiences of living with diabetes, three stages 
have been identified: adapting to the diagnosis, learning to live with type 1 diabetes, and 
becoming independent. For teens, the key to developing self-management skills and 
independence was experimental learning. Parents and health professionals must create 
conditions that give adolescents the freedom to learn through trial and error (98). 
Furthermore, themes identified in communication between children and parents are 
frustration, fear, normalizing, trusting, and discounting (99).  
Babler et al. defined normalization as ‘the ability to integrate diabetes into one’s daily life to 
make diabetes ‘part of me’, and identified six codes describing actions by adolescents during 
each phase (normalizing during each phase): remembering the journey (recognizing that life 
is changing), balancing blood sugar/preventing a crisis (taking action to prevent a crisis), 
integrating diabetes with the world outside the home (disclosing to engage support), moving 
the journey towards independence (taking on the burden of care), figuring it out (accepting 
the new normal), and helping others (hoping for a normal future). One of the most crucial 
periods is when the adolescents are ‘moving the journey towards independence’, taking more 
responsibility, having more conflicts with their parents, and realizing that diabetes self-care is 
a challenge. Gradually, they take full responsibility for the disease, ‘taking on the burden of 
disease’ (100, p. 650). Adolescents having difficulty moving into this phase may feel 
different and experience diabetes as a burden, which results in conflicts and unsatisfactory 
diabetes self-management. When they manage to figure out how to handle their diabetes they 
gain greater self-confidence, which means they can move on and help others learn how to 
manage their own diabetes (101). 
Adolescents were asked to identify their top three stressors, rate them on a scale from 1-10, 
and describe what was stressful about them. The top three stressors were: school (82%), 
social life (49%), and diabetes (48%). Diabetes did not substantially contribute to school 
stress (6.7%) or social life stress (4.3%). When the text was qualitatively analysed, general 
life stressors were identified (‘fitting in, having friends, balancing competing demands, 
living with family, and feeling pressure to do well’), as were diabetic specifics (‘just having 
diabetes, dealing with emotions, and managing diabetes’) (20) p. 137.  
Parents and adolescents perceive the level of parental support equally. On the other hand, 
youth experience lower levels of shared responsibility. However, a higher level of support is 
associated with a higher level of shared responsibility (102). In the same manner, there is an 
association between shared responsibility and better psychosocial health, satisfying self-care, 
and acceptable glycaemic control (103).   
In a study, adolescents were divided into three HbA1c groups (ideal <58.8 mmol/mol, 
satisfactory 58.9 -69.4 mmol/mol, and poor >69.4 mmol/mol). No differences in self-
management were identified between the groups (104). On the other hand, results from a 
study by Scholes et al. describe how adolescents with non-satisfactory glycaemic control 
believed type 1 diabetes was curable, had negative experiences of receiving the diagnosis 
diabetes, neglected diabetes self-care, 
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more satisfactory glycaemic control knew diabetes could not be cured, had less negative 
experiences of being diagnosed, practiced good diabetes self-care, and received parental 
support (105). 
3.3.3# Parental#support#
It is known that relations between parents and adolescents are of great importance to diabetes 
self-management, and several studies indicate an association between family conflicts and 
glycaemic control (106-112). Both adolescents and parents describe that responsibility shifts 
from parent to adolescent as age increases (112, 113), and that diabetes-specific family 
conflicts are not associated with age (112). However, diabetes-specific family conflicts, older 
age of children, longer diabetes duration, insulin delivery via injections versus CSII, greater 
depressive symptoms, and ethnic minority predict poorer diabetes self-management and 
glycaemic control (109). Common reasons for conflicts are nagging (primarily about blood 
glucose testing), logging results, and meals (47, 114). Other reasons include parental anxiety 
and intrusive behaviours, including parents’ lack of understanding as well as criticising 
behaviour (115). When there is discrepancy in the parents’ and children’s reported 
experiences of the frequency of communication, results from previous research indicate an 
association with poor glycaemic control and more conflicts. Parents usually feel they have 
frequent communication, while adolescents experience this less. Adolescents who 
experienced a more positive tone in conversations with their parents also had a better 
glycaemic control (107). Parents’ ability to cooperate seems to affect family conflicts (116) 
and glycaemic control (117). 
Adolescents with poor glycaemic control experience more conflicts with peers, more negative 
feelings about diabetes and fewer blood glucose tests, and miss clinic appointments more 
frequently (118). Symptoms of anxiety increase in families with a great deal of conflicts, 
which could have a negative effect on glycaemic control (108). It is known that family 
conflicts are associated with self-efficacy (119). On the other hand, the effect diabetes-related 
family conflicts have on glycaemic control might be mitigated by self-efficacy (120).  
In a Norwegian study, adolescents with type 1 diabetes reported that their parents were more 
involved and controlling, compared with the reports of healthy and disabled adolescents. No 
association was found between glycaemic control and QoL (93). Research on the effect of 
parental involvement and care on glycaemic control shows divergent results. Some studies 
show that parental care, control, and involvement are not related to glycaemic control (93, 
113). At the same time, research has shown that parental involvement is a predictor of the 
frequency of glucose monitoring (106). Agreement between parents and adolescents and 
fewer diabetes-related conflicts are predictors of glycaemic control (113, 121) and better 
HRQoL (121). This strengthens the results presented by Olinder et al. describing the need to 
clarify responsibility in order to avoid missed insulin doses (122). In a qualitative interview 
study, adolescents were divided into two groups according to their HbA1c levels (low group 
<63.9, high group >63.9). Adolescents in the low group described their parents’ rules more 
positively, while adolescents in the high group were irritated by reminders and described 
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more diabetes-related conflicts with their parents (123). Adolescents with parents who were 
perceived to be over-involved in diabetes care have worse glycaemic control. The greater the 
disagreement between adolescent and parents regarding responsibility for diabetes self-
management, the worse glycaemic control (124). 
In families with parents living together, the adolescents have better glycaemic control than 
those in single-parent families (124, 125). On the other hand, Dashiff et al. indicate that 
conflicts or adherence have no association with self-care in different family structures, or 
whether or not the mother works (126).  
In families with a warm and nurturing home environment with positive emotional support 
and communication, children and adolescents experienced higher levels of self-care and a 
lower impact of diabetes, had fewer worries about diabetes, and experienced greater life 
satisfaction, but no association was found with glycaemic control (127). Main et al. describe 
that parental support is associated with better diabetes self-management. Mothers reported an 
association between conflicts and inadequate diabetes self-management and more depressive 
symptoms. On the other hand, adolescents reported no correlation between conflicts with 
parents and diabetes self-care or depression (128). In families describing household chaos, a 
correlation with glycaemic control has been indicated (129).  
From a long-term perspective, an authoritative parenting style seems to work the most 
effectively. It gives teens the space to develop in accordance with their needs and their sense 
of what they want. Experimentation can then take place under the safest conditions possible, 
in consultation with parents who put reasonable limits in place. Parents need to be able to 
justify prohibitions and requirements. This parenting style should not be confused with an 
authoritarian style, which can be compared with military-style parenting, whereby parents 
want to dictate how their teens behave (87). A study by Mlynarczyk et al. showed a 
difference in adherence between adolescents perceiving their parents as authoritative and 
those perceiving their parents as authoritarians, permissive, or neglectful. In families with an 
authoritative parenting style, better adherence and perceived QoL were identified. However, 
there was no difference in HbA1c between the parenting styles (130). 
 
3.4# PATIENT#EDUCATION#
Recommendations from ISPAD highlight that education for adolescents with type 1 diabetes 
should be structured, person-centred, and flexible. Education focusing on the acquisition of 
knowledge rarely leads to behavioural change. Consequently, educational interventions are 
most effective if they are based on psychoeducational theories, are integrated into clinical 
activities, have parental involvement, and use cognitive behavioural methods related to 
problem-solving, communication skills, assigning goals, dealing with family conflicts, coping 
skills, and stress (17). 
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The new Medical Research Council guidance recommends that available evidence and 
appropriate theories should be used when developing an intervention, and that a pilot study 
should be carried out (131). Ayling et al. have recently published a review evaluating the 
efficacy of theory-based RCT interventions aimed at behavioural change in young people 
with type 1 diabetes, published between July 1999 and November 2012 (132). Using the 
template for quality audit for systematic reviews according to AMSTAR (a measurement tool 
for assessing the methodological quality of systematic reviews), the review meets the basic 
requirements for quality (133). However, it includes studies with a wide range of 
interventions, with durations ranging from 1 hour to 15 months. The results show that 30% of 
included studies do not mention or describe any explicit use of theory. Overall, there was an 
effect on HbA1c for intervention participants, with an effect size of 0.16 (95% CI: 0.01-0.30), 
and for those explicit uses of theory there was a better effect of 0.22 (CI: 0.07-0.36). The 
results were moderately heterogeneous (I2= 51.6%). For studies that mentioned or explicitly 
used theory, there was an effect on psychological outcomes (132).  
However, there are some problems with meta-analysis, as the combined effect is not a 
reliable estimate of the ‘true’ effect. Firstly, it may be that the results included are not a 
representative sample, due to a problem known as publication bias. Usually, this means that 
the estimated effect is too large. Secondly, the results are based on studies that are not 
sufficiently similar to the others (normally called clinical heterogeneity), and may be 
presented in either an overestimation or underestimation of the ‘true’ effect (133).  
3.4.1# Power#and#selfHefficacy#
It is important to highlight the patient’s own power to manage a lifelong chronic disease. 
According to Barrett, power in healthcare is ‘the capacity to participate knowingly in 
change’, and consists of four inseparable dimensions – awareness, choices, freedom to act 
intentionally, and involvement in creating change. Two forms of power that may play a role 
in education are empowerment and social power (134, p. 48).  
One of the most widely used definitions of empowerment is the one defined by Funnell and 
Anderson: ‘the discovery and development of one’s inherent capacity to be responsible for 
one’s own life’ (135, 136, p. 454). ‘Patients are empowered when they have knowledge, 
skills, attitudes, and self-awareness necessary to influence their own behaviour and that of 
others in order to improve the quality of their lives’ (135, p. 38).  
The most common description of social power is the one by French and Raven, who divided 
it into five forms, of which referent and expert power are relevant in this context. Referent 
power is defined as the ability of some individuals to be a reference and to have significant 
importance for others. They can induce changes in the attitudes, values, and decisions of 
others. A person with referent power is benevolent and caring. Expert power is knowledge 
from a person that results from experience or education (137, 138).  
Self-efficacy is a person’s feelings and thoughts about his/her own capability. How active a 
person is in his actions is linked to the strength of a person's self-efficacy. Those who expose 
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themselves to subjectively perceived threatening situations will gain experiences that enhance 
their self-efficacy and, gradually, their defensive posture (139).  
3.4.2# PersonHcentred#approach#
While it is difficult to describe what a person is, it could be based on four ethical concepts: 
autonomy, dignity, integrity, and vulnerability. Autonomy means being able to choose your 
own path in life. Dignity makes a connection to other people, a respect for others who have 
the same rights and obligations as you do. Integrity means not to hurt, harm or destroy other 
people’s lives, but to protect the person in the context of life and his/her life history. Finally, 
vulnerability constitutes an essential determination of the human as a mortal being. It should 
not be interpreted as a weakness, but as the inherent structure of human finiteness (140). 
According to Paul Ricœur, a human being is considered capable and can take responsibility 
for actions and decisions. He/she is capable of prioritizing and motivating decisions. Ricœur 
believes that ethics is superior morality, but that the ethical quest should be tested against 
moral norms. He sums up the meaning of ethics as a quest for a good life with and for others 
within the institutions of justice. Firstly, ethics ultimately concern what makes life worth 
living. Secondly, ethics entail a quest involving interpersonal dimensions ‘with and for 
others’. A happy human needs friends. Mutuality in interpersonal relationships requires that 
you take the other seriously. The third part of the ethic quest is ‘within the institutions of 
justice’ (141). However, it is important to be aware that, during adolescence, cognitive ability 
develops from a limited capability for abstract thinking regarding understanding the 
consequences of actions to a more realistic analysis and view of the future (88). 
Person-centred care includes patients being seen based on their context, strengths and future 
plans, and their rights being taken into account. Person-centred care highlights the 
importance of knowing the person behind the patient in order to engage the person as an 
active partner in his/her own care and treatment. The person’s story is central and, in 
partnership with the medical staff, determines actions meeting the person’s expectations and 
goals, which should be documented (142).  
Many of our beliefs are collectively nurtured and maintained. A dialogue is a process that 
offers the opportunity to reflect on and change these self-imposed limits. According to Buber, 
dialogue is a prerequisite in meeting, whereby people can soften or release the obstacles 
between them, perhaps even defeat them, and achieve a real meeting (143). Dialogue is 
central in education programmes using conversations. To achieve dialogue, it is important for 
participants to understand each other’s perspectives; through this, conditions are created that 
allow them to discover perspectives other than their own (144). However, at the same time, 
conflict is a prerequisite for action. There is no norm for what is right or wrong in a given 
situation, but a human being is able to take responsibility for his/her actions and decisions 
(141). 
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3.5# EDUCATIONAL#INTERVENTIONS#
3.5.1# Guided#SelfHDetermination#(GSD)#
Using grounded theory, Vibeke Zoffman explained barriers to empowerment that were 
seldom overcome by health professionals. Based on this, along with other theories, she 
developed a method she named Guided Self-Determination (GSD) (145). GSD is an 
empowerment-based, person-centred reflection and problem-solving method intended to 
guide the patient in becoming self-determined and developing life skills for managing 
difficulties in diabetes self-management (146). Life skills are defined by WHO as: ‘abilities 
for adaptive and positive behaviour, that enable individuals to deal effectively with the 
demands and challenges of everyday life’, and examples include ‘decision-making, the 
ability to solve problems, creative and critical thinking, communication, communication 
skills’ (40, p. 360). The definition of self-determination in GSD is: ‘Quality of human 
functioning that involves the experience of choice, in other words, an internal perceived 
locus of causality; Self-determination is the capacity to choose and to have those choices be 
the determinants of one’s action’ (145, p.8). GSD is a method intended to facilitate 
meaningful and effective problem-solving between patients and healthcare professionals. 
Both parties are guided by the method of using their inherent capacity, individually and 
together, in a process that promotes patient life skills (146-148).   
To make the method clinically useful, Zoffmann added reflection worksheets based on 
several theories (145). By using the completed worksheets together with communication 
methods – mirroring, active listening, and value-clarifying responses – GSD helps the patient 
and the healthcare professional overcome barriers to empowerment. In mirroring, the group 
leader ‘mirrors’ (rather than interprets), repeating what the other has said or done. This gives 
the other person an opportunity to observe him/herself from outside. In active listening, the 
group leader usually concludes the mirroring and thereafter interprets the total message, 
asking if the interpretation is correct. Finally, in value clarification, values and aims are 
linked. The group leader expresses a response or question that encourages a reassessment of 
values. The person is encouraged to make informed choices (145-148). GSD has been 
effective in both individual and group training for adults with type 1 diabetes (149, 150). The 
method has been adapted for teenagers, in the GSD-Young (GSD-Y) in Denmark. In an RCT 
including 71 adolescents (aged 13-18 years), 37 received an intervention with GSD-Y. The 
results showed no significant reduction in HbA1c, but did show improvements in the 
patients’ motivation for diabetes self-management. Further, adolescents expressed growth in 
life skills, which to them meant new relationships with health professionals and their parents, 
and increased decision-making competence as well as personal maturity (151, 152).  
3.5.2# Empowerment#based#education#
Viklund et al. performed an RCT with an empowerment intervention for a six-month period 
including 32 adolescents (aged 12-17 years). The education programme consisted of six 
sessions (2 h) once a week. Each time, a topic was raised based on the empowerment 
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concept: life satisfaction and goal-setting, problem-solving, coping with emotions, coping 
with daily stress, social support, and motivation.  
There was no difference in glycaemic control or empowerment between the intervention and 
control groups six months after intervention. For adolescents aged over 14 years, HbA1c was 
significantly higher six and 12 months after intervention, but had decreased to baseline after 
18 months. All groups were offered an extra opportunity to invite their parents and inform 
them about the content of the education. Two invited their parents, two allowed the group 
leader to meet their parents, and two did not want to invite their parents. There were no 
differences in HbA1c in these groups at baseline; however, in the group whose parents were 
not invited, HbA1c had increased 12 months after the intervention. The group that invited 
their parents showed significant improvement in HbA1c 12 and 24 months after the 
intervention (p<0.05) (153). Two weeks after completing the empowerment education, the 
adolescents were interviewed in order to explore teenagers’ perceptions of factors affecting 
decision-making competence in diabetes management. Five categories were revealed: 
cognitive maturity, personal qualities, experience, social network, and parent involvement. 
Furthermore, an overall theme was formulated: ‘Teenagers deserve respect and support for 
their shortcomings during the maturity process’ (95, p 3265). 
3.5.3# Structured#education##
The CASCADE (Child and Adolescent Structured Competencies Approach to Diabetes 
Education) is a comprehensive prospective multicentre RCT including 362 participants aged 
8-16 years with type 1 diabetes, and their parents, involving 28 paediatric diabetes clinics in 
the UK. The participants, randomized to intervention or control, were followed for 24 
months. The intervention consisted of four modules over four months. Each session lasted 
approximately two hours, and was held by paediatric diabetes specialist nurses and dietitians. 
In the sessions, two psychological approaches were used: motivational interviewing and 
solution-focused brief therapy. The intervention provided both structured education and a 
model in order to motivate the participants and their parents to reflect on their own self-
management approach.  
The results showed that, of the included participants, only 30% attended all sessions in the 
intervention group, 53% attended at least one session, and 68% of the possible groups were 
carried out. Some staff described that they found it difficult to manage the psychological 
techniques, and experienced it as burdensome to organize the groups. The participants 
experienced the intervention as positive and as resulting in: improved relationships in the 
family, increased knowledge and understanding of diabetes, increased security, and increased 
motivation to perform self-management. The results of the study showed no differences in 
HbA1c between the groups at 12 or 24 months (154). 
3.5.4# SelfHmanagement#education#
Cai et al. describe the development and pilot test of an education programme involving a self-
management approach including 22 children and adolescents aged 8-16 years and their 
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parents. The participants were divided into seven groups based on the youth’s age. The 
intervention consisted of a whole day workshop focusing on the overall management of blood 
glucose management and the challenges of diabetes in everyday life. The participants found 
the day with the workshop useful and enjoyable. The parents appreciated listening to the 
youth’s experiences. Both parents and the youth appreciated meeting others and sharing their 
experiences of living with diabetes. Although many had a high level of diabetic knowledge, 
they experienced that they had learned new things. As this was a feasibility study, including 
only 22 participants, no statistical analyses have been performed. However, HbA1c levels 
were about the same before and after the intervention: 66 + 12 mmol/mol before and 65 + 13 
mmol/mol after (6-12 months) (155). 
3.5.5# Coping#skills#training##
Coping-skills training has been carried out in RCT interventions involving pre-adolescent 
children. Ambrosino et al. and Grey et al. reported on a study with 111 children and 
adolescents aged 8-12 years, and Holmes et al. (2014) on one with 226 adolescents (aged 11-
14 years). Neither of these had a proven effect on glycaemic control (156-158). Grey et al. 
reported positive effects for both the intervention group (receiving coping-skills training) and 
control group (receiving general diabetes education) on diabetes impact, coping skills, self-
efficacy, depressive symptoms, and parental control (159). In the study by Holmes et al., the 
intervention group received coping-skills training and the control group received diabetes 
education as a supplement to quarterly visits. Both groups prevented deterioration in diabetes 
care and improved QoL in children and parents, including indicators of more effective 
communication. Adherence barriers decreased without increasing diabetes-related conflicts 
(158).  
3.5.6# Cognitive#behavioural#therapy#(CBT)#and#motivational#interviewing#(MI)#
A systematic review was performed in 2009 by the Swedish Agency for Health Technology 
Assessment and Assessment of Social Services (SBU), regarding education for adults with 
diabetes. For persons with type 1 diabetes, the report showed insufficient scientific evidence 
regarding the efficacy on HbA1c or QoL of interventions with CBT, both individual and 
group-based, and no difference in effect on glycaemic control when using motivational 
interviewing (MI) compared with usual care (160). There are no studies on children and 
adolescents with results regarding interventions with CBT. 
Channon et al. performed a multicentre RCT comparing MI with support visits in 66 
adolescents (aged 14-17 years). The intervention lasted for 12 months, and follow-up data 
were collected 6, 12 and 24 months after baseline. There was a significantly lower HbA1c in 
the intervention group at 12 months, and this was maintained at follow-up 24 months after 
start (161). Fifty-four adolescents (aged 12-18 years) were included in an RCT using MI with 
a control group receiving structured diabetes education (SDE). The intervention lasted three 
months. In the results of this study, the SDE group showed significantly better HbA1c than 
the MI group at nine months after study start (162).  
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DEPICTED (the Development and Evaluation of a Psychosocial Intervention in Children and 
Teenagers Experiencing Diabetes) is an MI-inspired programme in which patient and 
personnel set the agenda together and use different communication methods. The programme 
involved 693 young persons (359 intervention) aged 4-15 years from 26 centres. For the 
intervention, 79 healthcare workers from 13 centres were trained in the method. These 
healthcare workers were trained to put the patient in the centre through more constructive 
consultations, in order to achieve behavioural changes. Despite this, there were increases in 
HbA1c in both groups at follow-up after one year. Mean HbA1c (SD) at baseline vs. follow-
up were 9.2 (1.8) vs. 9.5 (1.7) for the control group and 9.4 (1.7) vs. 9.7 (1.7) for the 
intervention group (163).
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4# GENERAL#AND#SPECIFIC#AIMS#
 
4.1# GENERAL#AIM#
The overall aim of this thesis was to increase the knowledge regarding glycaemic control, 
type of treatment, HRQoL, and a theory-based education among youth with type 1 diabetes. 
 
4.2# SPECIFIC#AIMS#
•! To investigate long-term effect on glycaemic control, ketoacidosis, serious 
hypoglycaemic events, insulin requirements, and body mass index standard deviation 
scores (BMI-SDS) in children and adolescents with type 1 diabetes starting on continuous 
subcutaneous insulin infusion (CSII) compared with children and adolescents treated with 
multiple daily injections (MDI) (Paper I). 
 
•! To test the validity and reliability of the Check your Health by proxy instrument in 
parents to children (aged 8-17 years) with diabetes (Paper II). 
 
•! To evaluate whether an intervention using Guided Self-Determination-Young in groups 
of adolescents starting on continuous subcutaneous insulin infusion and their parents 
leads to improved glycaemic control, increased perceived health and HRQoL, fewer 
diabetes-related family conflicts, and improved self-efficacy (Paper III).  
 
•! To describe adolescents’ perceptions of participation in group education with the Guided 
Self-Determination-Young method together with parents, in connection with the 
introduction of continuous subcutaneous insulin infusion (Paper IV)
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5# METHOD#AND#PARTICIPANTS#
 
5.1# STUDY#DESIGNS#
In this thesis, both quantitative and qualitative methods have been used. An overview of the 
studies is presented in Table 2. 
Table 2. Overview of designs, data collection year, participants, data collection, and analyses. 
Paper Design Data 
collection 
(years) 
Participants Data collection Analyses 
I Retrospective 
descriptive 
study 
2005-2011 Starting CSII 
(n=216)  
Control MDI 
(n=215) 
Gender, age, HbA1c, 
insulin requirement, 
BMI, BMI-SDS, 
ketoacidosis, and serious 
hypoglycaemic events. 
Descriptive 
rANOVA 
Independent and 
dependent t-test 
II Psychometric 
properties of 
evaluation 
instrument  
2011-2014 197 parents 
and their 
children 
Proxy and child versions 
of Check your Health and 
DISABKIDS 
Spearman’s rank 
correlation 
Mann-Whitney U-
test  
Wilcoxon signed 
rank test  
III Randomized 
controlled 
multicentre 
study 
2012-2017 71 patients 
(11.5-18.1 
years) starting 
CSII and their 
parents 
At start, 6 and 12* 
months: HbA1c, height, 
weight, Check your 
Health, DISABKIDS, 
DFCS, Swe-DES, 23, 
and usage of FGM or 
CGM. At 6 and 12* 
months usage of CSII 
Spearman’s rank 
correlation  
Mann-Whitney U-
test 
Wilcoxon signed 
rank test  
Multiple linear 
regression analysis 
IV Qualitative 
interview 
study 
2015-2016 13 adolescents 
(12-20 years) 
from the 
intervention 
group in Paper 
III  
Individual interviews Qualitative content 
analysis 
* The analyses for 12 months are not included in this thesis. 
 
5.2# PARTICIPANTS#AND#SETTING#
Paper#I#
This was a retrospective study collecting data from a total of 431 children and adolescents at 
Karolinska University Hospital, Astrid Lindgren Children’s Hospital, Stockholm, Sweden. Of 
those, 216 were starting CSII during the period 1 January 2005 to 31 December 2009. 
Inclusion criteria were insulin requirement of more than 0.5 u/kg/day to exclude the effects of 
own residual insulin secretion (164). Patients with incomplete follow-up data, use of CGM 
during the entire period, or long-acting insulin together with CSII were excluded. Each 
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patient was matched for age, sex, and HbA1c levels to one control on MDI with direct-acting 
insulin analogues; in total, 215 controls were included. The control group was collected from 
SWEDIABKIDS at the same hospital (Figure 1).  
 
Figure 1. Flowchart for eligible, excluded, and included participants in Paper I. 
 
Paper#II#
Parents (n=197) and their children with type 1 diabetes were consecutively recruited from 
Karolinska University Hospital, Astrid Lindgren Children’s Hospital, Stockholm, Sweden, 
and Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden, during visits 
to the diabetes clinic. Inclusion criteria were children aged 8-17 years with a duration of type 
1 diabetes of more than six months, and one of their parents. Both children and parents 
understood written Swedish.  
Papers#III#and#IV#
Recruited participants were aged between 11.5 and 18.1 years and starting CSII at Sachs’ 
Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden, and Astrid Lindgren’s 
Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden. At study start, 
inclusion criteria were: diagnosed with type 1 diabetes for more than 12 months, HbA1c >63, 
insulin requirement >0.5 U/kg, not using CGM at start of CSII, and able to speak and 
understand the Swedish language (both the adolescents and their parents). Power calculation 
(power 80% and alpha 0.05) indicated that, to show a difference of 6 mmol/mol in HbA1c 
(SD: ± 9.1), each group had to contain at least 37 participants. At study start 160 patients at 
the clinics in question fulfilled the inclusion criteria, and from these mean HbA1c and 
standard diviation (SD) were calculated: 74.2 ± 9.1 mmol/mol. 
   25 
During the inclusion period of November 2012 to November 2016, levels of HbA1c have 
significantly improved and the use of CGM/FGM has increased at the clinics in question (2), 
resulting in difficulty recruiting participants. In addition, the Swedish guidelines’ 
recommendation for HbA1c has been lowered to 48 mmol/mol, which is consistent with 
recommendations by the National Institute for Care Excellence in the UK (NICE) (8, 9). 
Therefore, the HbA1c level for inclusion was lowered to >56 mmol/mol and the use of 
CGM/FGM was accepted. Furthermore, the criteria for diabetes duration were lowered to six 
months or more. In total, 71 youths were included during the inclusion period (Figure 2). 
Of the 37 youths completing the intervention, 14 (7 boys and 7 girls 12-20 years) were asked 
to participate in an interview study. Of these, one girl declined participation (Figure 2). 
Purposeful sampling was used with maximum variation was used to select the participants. 
Purposeful sampling is widely used in qualitative research for the identification and selection 
of information-rich cases related to the phenomenon of interest (165). 
 
* Results from 12 months analyses are not presented in this thesis. 
Figure 2. Flowchart of Papers III and IV. 
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5.3# INTERVENTION#
Paper#I#
The start of CSII described in Paper I was performed in groups consisting of three to six 
children and at least one of their parents (preferably both). All the participants starting CSII 
received a structured theoretical and practical education, including knowledge related to 
using the insulin pump, and education in hyperglycaemia, ketoacidosis and hypoglycaemic 
events. At the clinic, a checklist had been developed and was used to ensure the quality. 
Education at the start of CSII was mainly conducted by the diabetes nurse. A physician 
(specialized in paediatrics and endocrinology) was responsible for the calculation and 
correction of doses, and for the education about ketoacidosis and hypoglycaemic episodes. 
The start included a full day (6 hours) and two half days (3 hours each) education. One week 
after start of CSII, the group met for follow-up and evaluation of insulin doses. Four to six 
weeks after the follow-up visit, the patients were individually booked with their parents to 
visit a physician. Thereafter, they received standard care according to ordinary routines, 
which meant visits to a nurse or physician at three-month intervals. 
Paper#III#and#paper#IV#
All adolescents and their parents attended a standard insulin pump introduction programme, 
offering education and practical training in areas including technical skills and how to use 
carbohydrate counting with CSII. In addition, one parent for each child was offered the 
possibility to voluntarily simulate diabetes by wearing an insulin pump containing saline and 
test their glucose values before the child started the insulin pump treatment. After this, the 
control group received standard care according to ordinary routines.  
The intervention group attended seven group education sessions using the GSD-Y method 
(146, 147). Each session lasted about two hours, and was led by two group leaders (two 
diabetes nurses, or one diabetes nurse and one dietician). All group leaders had received 
education in the method from its creator, Vibeke Zoffmann. Three of the sessions were held 
in connection with the start of CSII, and thereafter about once a month for the remaining four. 
Before each session, the participants completed a specific reflection worksheet i.e. one 
worksheet per session. The first worksheet was sent to the participants before their first 
session. For subsequent sessions, the worksheet for the next meeting was distributed at the 
current one (Table 3). The parents completed reflection worksheets at Sessions 3, 4 (room for 
diabetes in your life), 5, and 7. To support patients in the dialogue at each session to allow 
them to express and consider difficult issues that emerged when using the reflection 
worksheets, the group leader used various communication methods (mirroring, active 
listening, and value-clarifying responses) (146). 
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Table 3. Overview of content of the reflection worksheets used at the GSD-Y sessions. 
Session 1 (Start CSII) Your life with diabetes from the beginning to now 
•! Written invitation to work together in a new way 
•! Two ways of looking at HbA1c 
•! Agreement on things to work on 
Session 2 (Start CSII) Your life with diabetes from the beginning to now 
•! Important events and periods in your life 
•! What do you find difficult at present living with your diabetes? 
•! Your plans for changing your way of life 
Session 3 (Start CSII) Values and opportunities 
•! Unfinished sentences: needs, values, experiences and opportunities? 
Session 4 Diabetes in your life  
•! A picture or expression describing your life with diabetes 
•! Room for diabetes in your life 
•! Shared responsibility between adolescent and parent(s) for diabetes in 
daily life  
•! Common name for a difficulty in your life with diabetes 
•! Agreement on things to work on until next visit 
Session 5 Problem identification and problem-solving  
•! Current and dynamic problem-solving 
•! Agreement on things to work on until next visit 
Session 6 Different ways of looking at numbers 
•! Blood glucose tests and your reasons for checking 
•! Actual numbers of blood glucose tests and wishes 
•! Your plan for blood glucose regulation in the short and long run 
•! Common name for a difficulty in your life with diabetes 
•! Agreement on things to work on until next visit 
Session 7 Problem identification and problem-solving  
•! Current and dynamic problem-solving 
•! Solved problems and subjects to continue working on 
 
5.4# DATA#COLLECTION#
5.4.1# HbA1c#
In Paper I, HbA1c values were collected from the patient’s medical record or 
SWEDIABKIDS. HbA1c levels were measured using high-performance liquid 
chromatography on filter paper or the DCA 2000 apparatus (Siemens Medical Solution 
Diagnostics, Mölndal, Sweden). All values collected before 2011 were converted to Swedish 
Mono-S standard (Mono-S gives an approximately 1% lower result than DCCT’s HbA1c 
units). A consensus on a global standardization of the HbA1c measurement was approved in 
2007, recommending that HbA1c level should be reported in IFCC units (mmol/mol) (166). 
Therefore, our results in Mono-S (%) were converted to IFCC (mmol/mol) and to DCCT (%) 
values (167). 
In paper II and III HbA1c values were collected at clinical visits or from the medical record. 
HbA1c was analysed using DCA Vantage (Siemens Healthcare Diagnostics AB, Upplands 
Väsby, Sweden). 
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The grouping for HbA1c used in Paper II was based on ISPAD guidelines 2014 (<58 
mmol/mol, 58-75 mmol/mol and >75 mmol/mol) (7). 
5.4.2# BMIHSDS#
Body Mass Index (BMI, kg/m2) is an objective way to measure weight status. In children and 
adolescents there is age-related variation; therefore, reference values and tables have been 
developed for mean and standard deviation score (SDS) of BMI (BMI-SDS) (168).  
In Papers I and III, BMI-SDS was collected from the patient’s medical record and 
SWEDIABKIDS. 
5.4.3# Psychometric#measures#
DISABKIDS generic (DCGM-37) and diabetes-specific (DSM-10) questionnaire 
In Paper II, the DCGM-37 and DSM-10, both the child and proxy versions were used when 
validating Check your Health by proxy and in Paper III to measure HRQoL.   
DISABKIDS (DCGM-37) is a generic instrument for measuring HRQoL in children and 
adolescents with a chronic disease. The development of the instrument took place in seven 
European countries, including Sweden. After a pilot (53) and a field study were conducted, a 
final generic version emerged, the DCGM-37, containing 37 items (52, 54). The items are 
divided into six subscales with six to seven items in each domain: Independence, emotion 
(inner strength), social inclusion, social exclusion (equality), physical limitation (physical 
ability) and medication (treatment). The original domains are a mixture of positive and 
negative expressions; therefore, the negative ones were changed to positive and are described 
in brackets. Each item is rated on a five-point Likert scale (14, 52). The DCGM-37 has 
demonstrated acceptable reliability (Cronbach's alpha) (53, 54), good content validity (53) 
and acceptable construct validity (52-54). Schmidt et al. demonstrated a moderate effect size 
(ES) (0.33-0.72) (sensitivity) by comparing the different diagnosis groups (52).  
Parallel to the DCGM-37, seven disease-specific modules were developed, among them one 
for diabetes (DSM-10) (169). The DSM-10 consists of ten items and is divided into two 
domains: impact (acceptance) and treatment (14). In psychometric tests of the DCGM-37 and 
the disease-specific module for children with type 1 diabetes in Sweden and Norway, an 
acceptable convergent and discriminant validity has been demonstrated (14, 170). Fröisand et 
al. have shown acceptable reliability for the DCGM-37 and DSM-10 in Norway (170). 
However, reliability has not been tested on the Swedish population (14). For both DSGM-37 
and DSM-10, a proxy version for parents is available (54, 169). 
Check your Health 
In Paper II psychometric tests were conducted on Check your Health by proxy for parents, 
and in Paper III it is used to measure perceived health, social relations, general QoL, and 
burden of diabetes.  
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Check your Health, developed by Wikblad et al., is a measure that is short and easy to 
complete. It consists of four pages with one domain/item on each page. On each page there is 
a vertical scale (0-100). On the left side of the scale, there is a question regarding perceived 
physical and emotional health, social relations and general QoL today with diabetes. On the 
opposite side of the scale there is the same question, but ‘how you would imagine it without 
diabetes’. From each question, a line is drawn to the vertical scale (Figure 3) (56). Diabetes 
burden is the difference between the two lines. The limit values for no (0), low (1-10), high 
(11-29) or very high (>30) burden in Paper II are arbitrary. 
 
Figure 3. Description of the measure Check your Health. 
 
Diabetes family conflict scale (DFCS) 
In Paper III, the DFCS was used to measure how the adolescents perceived diabetes family 
conflicts (110). Sand et al. have translated and assessed the psychometric properties of the 
revised DFCS for children with type 1 diabetes and their parents in Sweden. It consists of 19 
items on diabetes management tasks, with each item rated on a three-point Likert scale 
(1=never arguing, 2=sometimes arguing, and 3= always arguing). The items are divided into 
two domains: around direct management (9 items) and around indirect management (10 
items). The total score can range between 19 (no conflicts) and 57 (highest degree of 
conflicts). The DFCS has shown acceptable reliability and validity for children, mothers and 
fathers (111). 
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Swedish Diabetes Empowerment Scale (Swe-DES 23) 
In Paper III, the Swe-DES was used to measure the psychosocial self-efficacy of people with 
diabetes. It consists of 23 items divided into four subscales: goal achievement, self-
awareness, managing stress, and readiness to change. Each item is rated on a five-point Likert 
scale ranging from strongly disagree (1) to strongly agree (5). It has been validated in 
Swedish for adults, and demonstrates acceptable internal consistency (Cronbach’s α for 
subscales: 0.68-0.91 and Cronbach’s α for total scores 0.91) (171). 
5.4.4# Interviews#
For Paper IV, an interview guide was designed according to the study aim. Semi-structured 
questions were asked about the group (e.g. what comes to mind when you think of the group 
sessions? What do you think was good about the sessions?), the parents (e.g. Can you tell me 
what it was like having your parents in the group? Can you tell me what things are like at 
home – has anything changed?), and diabetes self-management (e.g. Can you tell me what 
you think about having diabetes after having been involved in this programme?). 
Furthermore, probing questions were used. The adolescents were asked to describe their 
experiences as fully as possible. The interview guide was pilot-tested on three adolescents, 
and no major changes were made.  
For practical reasons, the interviews in Paper IV were conducted by two researchers. For 
consistency, the two researchers conducted the first three interviews together, with one 
performing the interview and the other serving as an observer, asking additional questions if 
needed. All interviews were recorded, and a secretary transcribed them verbatim.  
 
5.5# PROCEDURES#
Paper#I#
The patients were followed for 24 months, and data collection was done by review in the 
medical record system and the National Diabetes Register – SWEDIABKIDS. The collected 
variables are presented in Table 4. In addition, reported events of ketoacidosis (hospitalized) 
and severe hypoglycaemia (hospitalized or reported by patient) during the 24-month study 
period were collected. 
Table 4. Data collection in Paper I. 
At baseline and 6, 12, and 24 months •! Gender and age (only at baseline) 
•! HbA1c, insulin requirements, BMI, and BMI-SDS 
#
#
#
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Paper#II#
The participants, pairs of a parent along with their child with type 1 diabetes, were asked to 
participate in the study at an ordinary visit to the clinic. They completed the Check your 
Health, DCGM-37 and DSM-10 proxy and child versions before or directly after visiting the 
clinic. To test reliability, the questionnaires were sent two weeks later to 45 of the 197 
participants. Furthermore, current diabetes treatment and HbA1c were collected. 
Paper#III#and#IV#
In Paper III, those adolescents and parents who were positive to participate were 
consecutively divided into groups and randomized to either intervention or control. The data 
collection is described in Figure 2.  
The participants in Paper IV, the interview study, were asked to participate at their last visit in 
the GSD-Y intervention or by telephone. The interview guide was pilot-tested on three 
adolescents two months (two participants) and one year (one participant) after completion of 
the intervention. These adolescents remembered a great deal from the intervention, and the 
interviews were rich in information; however, they found it difficult to remember details from 
their work with the reflection worksheets. To increase the possibility that they would 
remember this information, the remaining interviews were conducted two to six weeks after 
completion of the intervention (10 participants). Interviews with the adolescents were 
conducted individually. Twelve were interviewed face-to-face, and one by telephone. All 
interviews were recorded. The adolescents were asked to describe their experiences as fully 
as possible. Ten interviews were conducted in a room outside the paediatric diabetes 
department at the children’s hospital, two in the participants’ homes, and one by telephone. 
The decision to conduct interviews in the participants’ homes or by telephone was made 
according to the participants’ wishes. 
 
5.6# QUANTITATIVE#DATA#ANALYSES#
In Papers I and II, data were analysed using the Statistical Package for Social Sciences 
(SPSS, version 21; IBM, Stockholm, Sweden). In Paper III, SPSS version 23 was used. The 
level of statistical significance was p<0.05. 
Paper#I#
In Paper I, descriptive statistics were used for baseline characteristics. The numbers of 
reported ketoacidosis and severe hypoglycaemic episodes are presented as episodes per 100 
person-years.  
When comparing HbA1c, insulin requirements and BMI-SDS over time and between CSII 
and MDI groups, repeated ANOVA (rANOVA) were used. Further, post hoc tests using 
independent (un-paired) Student’s t-test (two-tailed) were conducted to identify differences 
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between groups at different times (at baseline, 6, 12 and 24 months). Changes within groups 
(over time) between baseline and follow-up were calculated using dependent (paired) t-tests. 
The study population was divided into subgroups, and thereafter the same analyses were 
conducted as for the whole group: age 0–<7, 7–<12, and 12–18 years; gender; and 
participants with baseline HbA1c values above 70 mmol/mol. 
Paper#II#
In Paper II data on age, HbA1c, and diabetes duration were distributed normally; therefore, 
mean values (95% CI) have been used. However, results from Check your Health had a non-
normal distribution and therefore median values (range) were used. 
Floor (0) and ceiling effects (100) have been calculated, and are presented in the percentage 
scoring as either 0 or 100. Reliability and convergent validity were analysed using 
Spearman’s rank correlation. The Mann-Whitney U-test was used to analyse differences in 
independent (unpaired) samples, and the Wilcoxon signed rank test to compare dependent 
(paired) samples (child-parent pairs). Reliability was calculated through test-retest 
correlation, and convergent validity was calculated by analysing the correlation between 
Check your Health by proxy and DCGM-37 by proxy. In this thesis, the strength of a 
correlation <0.4 is regarded as low, 0.4–0.74 as good, and >0.74 as excellent (172).  
Paper#III#
Analysis in Paper III was done based on intention to treat. A non-normal distribution was 
found for all variables, and therefore median values (range) were used.  
Correlation was analysed using Spearman’s rank correlation. The Mann-Whitney U-test was 
used to analyse differences in independent (unpaired) samples, and the Wilcoxon signed rank 
test to compare dependent (paired) samples. Multiple linear regression analysis was used to 
examine which variable contributed the most to glycaemic control at six months. A model 
was created with forward stepwise regression; the model was validated for normally 
distributed error terms, homoscedasticity, linear function, independent error terms, outlier 
observations, and multicollinearity. 
 
5.7# QUALITATIVE#DATA#ANALYSES#
In Paper IV, qualitative content analysis inspired by Krippendorff was used in the inductive 
analyses (173). Content analysis is a general term for the identification, organization, and 
categorization of narrative text, and detects patterns and themes (165). The analysis was 
performed as described in Figure 4. 
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Figure 4. Description of the qualitative content analysis process. 
 
The categories were carefully assessed based on internal homogeneity (data belonging to the 
same category belongs together in a meaningful way) and external heterogeneity (the 
difference between the categories is clear) (165). The analysis was based on a manifest 
interpretation of the text. When all authors made a latent interpretation of the content, an 
overreaching theme was revealed. 
We have strived to achieve trustworthiness (credibility, dependability, confirmability, and 
transferability) by describing the analytical process in detail, providing quotations from the 
interviews (Paper IV), involving several researchers in the analyses, and describing the 
sample and context in as much detail as possible. The different intervals between intervention 
and interviews may have increased trustworthiness; the results were consistent despite the 
varying intervals (165, 174).  
 
5.8# ETHICAL#CONSIDERATIONS#
The Ethical Review Board in Stockholm, Sweden, has approved all studies (I, 2010/234-31/1, 
II, 2011/762-31/4, III and IV, 2011/762-31/4 and 2012/2124-32), which were carried out in 
accordance with the Declaration of Helsinki. The participants received oral and written 
information about the studies when they were asked to participate. Information was given that 
participation was voluntary, that they could discontinue whenever they wanted, that all 
collected data would be kept safe, and that it will not be possible for any information to be 
linked to any person. Written consent was obtained from the participants 
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(children/adolescents and parents in Papers II and III). In Paper IV, written consent was also 
obtained from a parent for those under15 years (175).  
None of these studies can be expected to present any risk or possible complication for the 
participants. In studies involving children and adolescents, it is important to be aware of the 
feeling of disadvantage that young people may experience in relation to adults. In Paper IV 
we were aware of this, especially during the first three interviews, in which two researchers 
participated. Therefore, we chose to start the interviews with everyday talk to create a good 
environment to encourage a meeting on equal terms. At the interviews, the participants were 
once again asked if they minded that the interview would be recorded, and if they were aware 
that the material would be transcribed verbatim. The results of the studies will be presented to 
the participants in the form of the Swedish summary of this thesis. 
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6# RESULTS#
 
6.1# GLYCAEMIC#CONTROL#
Paper#I#
In the study in Paper I, data were collected from 431 participants aged 1.1-17 years. Of these, 
216 children and adolescents started CSII treatment and 215 were recruited to the control 
group on MDI, matched for age, gender, and HbA1c (Table 5). In the CSII and MDI groups, 
the patients used rapid-acting analogue insulin (Insulin Lispro or Insulin Aspart); further, 
91% of the participants in the MDI group used long-acting insulin analogue (Insulin Glagine 
and Insulin Detemir), and during the study period 4% changed to long-acting insulin 
analogues.  
Table 5. Baseline characteristics of the CSII and MDI group, presented as mean (95% CI) for 
age, diabetes duration, and HbA1c.  
Characteristics CSII (n=216) MDI (n=215) p-value 
Female sex, n (%) 103 (48) 103 (47)  
0-6.99 y, n (%) 41 (19) 38 (18)  
7-11.99 y, n (%) 82 (39) 81 (38)  
>12 y, n (%) 93 (43) 96 (44)  
HbA1c >70, n (%) 83 (38) 84 (39)  
Age (range) 10.7 (1.9-17) 10.8 (1.1-16.9) NS 
   Female 11.1 (2.6-17) 11.2 (1.1-16.9) NS 
   Male 10.3 (1.9-16.8) 10.4 (2.5-16.9) NS 
Diabetes duration (Year) 4.6 (0.1-15.3) 4.1 (0.3-12.4) NS 
   Female 4.8 (0.3-15.3) 4.3 (0.3-12.4) NS 
   Male 4.5 (0.1-12.2) 4.0 (0.3-12.1) NS 
HbA1c (mmol/mol) 68 (66, 70) 68 (66,70) NS 
   Female, mean (95% CI) 71 (67, 74) 70 (66, 73) NS 
   Male, mean (95% CI) 65 (63, 68) 66 (63, 68) NS 
 
In the analysis, differences between the groups were identified at six and 12 months (p<0.001 
and 0.03, respectively) (Figure 5). In respect to changes over time (rANOVA), it was only for 
boys that a difference was identified (p=0.035) (Figure 6). For boys and girls, individually, a 
difference could be identified in both groups at six months, but it was only for boys that it 
remained at 12 months (p=0.023) (Figure 6). 
When the study population was divided into age groups (<7 years, 7-11.99 years and >12 
years), it was only at six months that a difference in HbA1c could be identified for 
participants older than 12 years (p<0.001). For those with HbA1c over 70 mmol/mol at study 
start, a difference was found at six months between the groups in favour of the CSII group 
(p<0.0001). 
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Figure 5. HbA1c levels in the CSII and MDI groups.  
 
 
 
 
 
 
 
 
Figure 6. HbA1c levels for boys and girls.   
 
In comparison with baseline, an improvement in HbA1c could be identified in the CSII group 
after both six and 12 months (p<0.001), while no changes could be identified in the MDI 
group. Likewise, this could be seen in boys and girls separately. When the study population 
was divided into age groups, no differences were found in the group with the youngest 
children (<7 years). For those in the CSII group aged 7-11.99 years, a difference was detected 
after six months (p<0.001). For the oldest participants (12-18 years) in the CSII group, 
improvements were detected after six and 12 months (p<0.001), and in the MDI group after 
12 months (p<0.05). For those with HbA1c over 70 mmol/mol at study start, improvements 
were detected in both groups after six months (CSII: p<0.001, MDI: p<0.05) 12 and 24 
months (p<0.001). 
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The numbers of reported ketoacidosis were 2.8 episodes/100 person-years in the CSII group 
and 0.5 in the MDI group (p<0.01). The incidence rates of severe hypoglycaemic episodes 
per 100 person-years were 3 in the CSII group and 6 in the MDI group (p<0.05). 
Paper#III#
The results presented in this thesis are from six-month follow-up. The data collection from 
the 12-month results will be completed at the end of 2017, and will therefore be analysed and 
published later. Seventy-one participants, aged between 11.5 and 18.1 (median 14.9) and 
starting CSII at the participating hospitals, were recruited. One participant was excluded after 
the start of CSII due to a diagnosis of MODY-3 diabetes and has not been included in the 
analyses. Median duration of diabetes was 4.2 years (0.5-14.8). HbA1c and BMI-SDS did not 
differ between the groups at inclusion. Descriptions of the participants at inclusion are 
presented in Table 6. 
Table 6. Baseline characteristics of the intervention and control groups 
Characteristics All 
(n=70) 
Intervention 
(n=37) 
Control  
(n=33) 
Mann-Whitney 
U-test, p-value 
Female sex, n (%) 42 (60) 20 (54.1) 22 (67)  
Age 14.9 (11.5-18.1) 14.8 (11.5-18.1) 15.3 (11.9-18.1) NS 
   Female (n=42) 15.0 (11.8-18.1) 15.0 (11.8-18.1) 15.0 (11.9-18.1) NS 
   Male (n=28) 14.8 (11.5-17-6) 14.8 (11.5-17.6) 15.6 (13.1-17.4) NS 
Diabetes duration, yrs  4.2 (0.5-14.8) 4.1 (0.5-12.5 4.4 (0.9-14.8) NS 
   Female  5.2 (0.7-14.8)  4.5 (0.7-12-5)  6.0 (1.0-14.8) NS 
   Male 3.1 (0.5-13.5) 3.4 (0.5-12.2) 3.0 (0.9-13.5) NS 
HbA1c* mmol/mol  
               DCCT %  
68 (52-130) 
8.4 (6.9-14) 
67 (52-101) 
8.3 (6.9-11.4) 
69 (56-130) 
8.5 (7.3-14) 
NS 
  Female mmol/mol 
               DCCT % 
71 (52-130) 
8.6 (6.9-14) 
66 (53-82)  
8.2 (7-9.7) 
72 (56-130) 
8.7 (7.3-14) 
NS 
   Male    mmol/mol 
               DCCT % 
67 (52-103) 
8.3 (6.9-11.6) 
67 (52-101) 
8.3 (6.9-11.4) 
67 (60-103) 
8.3 (7.6-11.6) 
NS 
BMI-SDS 0.60 (-2.94-3.14) 0.52 (-1.29-3.24) 0.76 (-2.94-2.89) NS 
   Female 0.76 (-2.94-3.14) 0.46 (-1.29-3.14) 1.34 (-2.94-2.89) NS 
   Male 0.42 (-1.15-2.51) 0.52 (-1.15-2.51) 0.33 (-0.67-2.4) NS 
*At inclusion 
 
Of the participants in the intervention group (n=37), 16 participated (43%) in seven sessions, 
11 (30%) in six sessions, five (13.5%) in five sessions and five (13.5%) in four sessions. 
Forty-eight patients (69%) had HbA1c >63 mmol/mol at inclusion, 23 (62%) in the 
intervention group (median 75, range 64-101), and 25 (76%) in the control group (median 72, 
range 66-130). 
A total of four participants (5.7%) – three in the control group (9.1%) and one in the 
intervention group (2.7%) – had stopped using CSII and restarted MDI at six months. Twenty 
patients (28.6%) – 11 in the control group (33.3%) and nine in the intervention group (24.3%) 
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– used CGM/FGM at baseline, as did 30 (42.9%) at six-month follow-up – 14 in the control 
group (42.4%), and 16 (43.2%) in the intervention group. 
Among all participants there was a decrease in HbA1c after six months with CSII (p<0.001). 
There were no differences between the intervention and control groups at inclusion or at six 
months. Among the participants with HbA1c above 63 mmol/mol (n=48) at inclusion, there 
was no difference between the groups at inclusion but there was at six months (p= 0.037) 
(Table 7). 
Table 7. HbA1c of the intervention and control groups at inclusion and 6 months. 
Characteristics All (n=70) Intervention Control p-value 
HbA1c mmol/mol     
   Inclusion 68 67 (n=37) 69 (n=34) NS 
   6 months 60* 58 (n=37) * 64 (n=32) * NS 
HbA1c >63 mmol/mol (n=48)     
   Inclusion 73 75 (n=23) 72 (n=25) NS 
   6 months 61* 57 (n=23) * 66 (n=25) * 0.037 
* p<0.01 compared with study start 
There was no difference in HbA1c between those who used CGM at baseline and those who 
did not (CGM: 64 mmol/mol vs. no CGM: 71 mmol/mol, p=0.439), or between those who 
used CGM at six months and those who did not (CGM: 60 mmol/mol vs. no CGM: 60 
mmol/mol, p=0.78). 
HbA1c did not correlate with HRQoL, measured with DISABKIDS (self and proxy versions) 
at inclusion. At six months, there was a weak correlation between HbA1c and diabetes 
acceptance (rs=-0.307, p=0.043).  
Measuring HRQoL with Check your Health, no correlations were found between HbA1c and 
the children’s perceived HRQoL at baseline. At six months, there were weak correlations 
between HbA1c and the children’s perceived physical health (rs=-0.305, p=0.037) and 
physical burden (rs=0.374, p=0.01).  
There were no correlations between HbA1c and DFCS at baseline. The difference in HbA1c 
between baseline and six months correlated with the difference in DFCS between baseline 
and six months (rs=0.479, p=0.002). At six months, there was a weak correlation between 
HbA1c and DFCSdir (rs=0.311, p=0.045).  
There was no correlation between HbA1c and the Swe-DES total or any domain at baseline. 
However, for total Swe-DES a correlation was detected at six months (rs=-0.439, p=0.003). 
Furthermore, there were correlations between HbA1c and goal achievement (rs=-0.475, 
p=0.001) and between HbA1c and readiness to change (rs=-0.487, p=0.001). 
Multiple linear regression analysis showed that the variations in HbA1c at six months could 
be explained by participation in the intervention group (p=0.001) and total score on the Swe-
DES (p<0.001) when adjusted for sex (R2 =0.45, p<0.001). 
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6.2# HEALTH#RELATED#QUALITY#OF#LIFE#
Psychometric#test#of#Check#your#Health#by#proxy#(Paper#II)#
We evaluated questionnaires from 197 parent-child pairs to test the psychometric properties 
of Check your Health by proxy. Characteristics of the children are presented in Table 8.  
Table 8. Characteristics of the children, presented as mean (95% CI), for age, diabetes 
duration and HbA1c. 
Variables All (n=197) Girls (n=95) Boys (n=102) 
Age, years 12.9 (12.6, 13.3) 12.8 (12.3, 13.3) 13.0 (12.6, 13.5) 
Diabetes duration, years 5.6 (5.1, 6.2) 5.8 (5.1, 5.6) 5.4 (4.7, 6.2) 
HbA1c, mmol/mol 64 (63, 66) 66 (64, 69) 62 (60, 65) 
 
The test-retest (reliability) for Check your Health by proxy for parents was moderate to 
strong: Physical and emotional health, social relations and QoL with diabetes (0.49–0.54), 
and burden of diabetes (0.48–0.74). The convergent validity between Check your Health by 
proxy and DCGM-37 by proxy was low to good (0.15–0.49). 
Our hypothesis for discriminant validity was: Parents estimate their children’s general QoL 
lower than the children do; and further, that higher HbA1c and more serious disease are 
associated with lower self-reported health and higher diabetes burden. This hypothesis was 
based on results from previous studies (14-16, 170, 176, 177).  
The results showed that the parents reported lower scores than the children on emotional 
health and social relations. Further, the parents estimated a higher burden of diabetes on 
physical and emotional health and QoL. There was no correlation between HbA1c and self-
reported health or burden of diabetes. Poorer social relationships and QoL were associated 
with higher severity of disease. The diabetes burden domain of Check your Health by proxy 
(emotional health, social relations and QoL) showed discriminant validity on perceived 
severity of diabetes. 
HRQoL#in#an#intervention#with#GSDHY#(Paper#III)#
When analyses were performed for all children, no differences were identified from baseline 
to six months in HRQoL or burden of diabetes. At baseline, there were differences between 
the groups in the domains of equality (p=0.008) and physical ability (p=0.005) in 
DISABKIDS (DCGM-37). Furthermore, a difference in physical burden at baseline, 
measured with Check your Health, was identified between the intervention and control 
groups (p=0.026). In the intervention group, an increase in physical ability was detected from 
baseline to six months (p=0.011). 
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DiabetesHrelated#family#conflicts#and#selfHefficacy#in#an#intervention#with#GSDH
Y#(Paper#III)#
The degree of family conflicts varied between 19 and 37 with a median of 24 at baseline, and 
between 19 and 44 (median 24) at six months. At baseline, the intervention group perceived 
more diabetes-related family conflicts (intervention 25 vs. control 22, p=0.037). The degree 
of conflicts decreased in the intervention group and increased in the control group, but the 
difference at six months was not statistically significant (intervention 24 vs. control 23, p= 
0.113).  
The DFCS scores correlated with those on the Swe-DES, at both baseline (rs=-0.421, p= 
0.002) and six months (rs=-0.54, p<0.001). 
For total scores on the Swe-DES, there were no differences between the groups at baseline 
(p=0.298) or at six months (p=0.265). However, the intervention group perceived a lower 
degree of readiness to change at study start (p=0.026). This difference was reduced after six 
months, as readiness to change increased in the intervention group (p=0.008) and remained 
unchanged in the control group (p=0.772) (Table 9).  
Table 9. Data of Swe-DES: total, goal achievement, self-awareness, managing stress and 
readiness to change at study start and 6 months reported as median (range). 
Characteristics  Intervention Control p-value 
Total score Study start 3.65 (3.0-5.0) (n=28) 3.87 (2.4-4.5) (n=26) NS 
    6 months 3.56 (2.9-4.9) (n=22) 4.0 (2.2-5.0) (n=23) NS 
Goal achievement Study start 3.7 (2.10-5.0) (n=33) 3.8 (2.3-4.8) (n=27) NS 
 6 months 3.6 (2.5-5.0) (n=22) 3.9 (1.8-5.5) (n=24) NS 
Self-awareness Study start 4.0 (2.8-5.0) (n=33) 4.0 (2.8-5.0) (n=27) NS 
 6 months 4.0 (2.9-5.0) (n=23) 4.5 (1.8-5.0) (n=24) NS 
Managing stress Study start 3.75 (2.2-5.0) (n=35) 3.62 (2.5-5.0) (n=28) NS 
 6 months 3.5 (2.2-5.0) (n=23) 4.0 (1.0-5.0) (n=24) NS 
Readiness to change Study start 3.6 (2.6-4.8) (n=30) 4.0 (1.4-5.0) (n=29) 0.026 
 6 months 4.0* (2.4-5.0) (n=22) 3.8 (3.2-5.0) (n=23) NS 
* p=0.008 compared with study start. 
 
Parents’#perspective#of#HRQoL#in#an#intervention#with#GSDHY#(Paper#III)#
The parents’ scoring on DISABKIDS and Check Your Health correlated with the children’s 
scoring. However, the fathers’ scoring of burden of diabetes did not correlate in the domains 
of emotional burden at six months and burden on quality of life at baseline and six months. 
The fathers perceived the children’s burden as lower than the children themselves did, 
especially in the control group.  
Differences between the groups among the fathers were detected at baseline in the domains of 
physical ability (intervention 69 vs. control 79, p=0.012) and treatment (intervention 62 vs. 
control 75, p=0.034); these differences had disappeared at six months (physical ability, 
intervention 73 vs. control 73, p=0.683 and treatment, intervention 67 vs. control 71, 
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p=0.312). Mothers reported a difference in general QoL at baseline, measured with Check 
your Health (intervention 77 vs. control 84, p=0.037), and this difference had also 
disappeared at six months (intervention 83 vs. control 89, p=0.463). Among the fathers, a 
correlation between HbA1c and perceived emotional health at baseline was found, measured 
with DISABKIDS (rs=-0.393, p=0.005).  
 
6.3# QUALITATIVE#EVALUATION#OF#AN#INTERVENTION#WITH#GSDHY#
In Paper IV, 13 out of 37 adolescents who had completed their education sessions with GSD-
Y were interviewed.  
From the analysis, two categories were revealed – the importance of context, and growing in 
power through the group process. Meeting others in the same situation is important; it creates 
a sense of belonging, and mitigates the feeling of loneliness. Sharing thoughts and 
experiences gives adolescents new ideas and tools for self-managing their diabetes in daily 
life. An overarching theme that emerged from the interviews was the importance of expert 
and referent power in growing awareness of the importance of self-management, as well as 
mitigating the loneliness of diabetes (Figure 7).    
 
Figure 7. Description of the overarching theme, main categories, and subcategories emerging 
in the analysis. 
 
#
#
#
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The#importance#of#the#context#
Participants 
The participants reported that meeting others with diabetes in their age group and situation 
was a positive and enjoyable experience. They experienced both advantages and 
disadvantages regarding the age distribution. Older adolescents expressed concern that the 
experience could be difficult as well as exciting and/or instructive for the younger 
participants, while younger participants described experiencing no barriers between the 
different age groups 
Location 
The adolescents found that having the sessions in the hospital was beneficial. Moreover, the 
groups were mixed and consisted of participants from all the clinics included in the study. 
Those who attended education sessions in a clinic they did not usually visit perceived this to 
be a positive aspect of the programme.  
Group leaders 
Participants emphasized the importance of the role of the group leader, and valued a positive 
and permissive atmosphere. It was positive that the group leaders were not the same people 
they usually met at their diabetes clinics. The leaders were therefore perceived as neutral – 
people with whom they could reflect on their experiences, rather than people whose job it 
was to take care of them.  
Reflection worksheets 
Overall, participants reported that the reflection worksheets used in the conversations were 
useful because they resulted in deeper reflection and allowed them to express themselves in 
different ways. They helped address issues they would not otherwise have discussed. Many 
of the younger participants needed help from their parents, both in completing the worksheets 
and during reflection work in the group. They perceived the reflection worksheets as too 
long, sometimes difficult to understand, and too time-consuming to fill in. 
In one session, the aim of the worksheet was to visually describe the participants’ images and 
thoughts regarding living with diabetes. This was appreciated and described as fruitful by the 
participants. Furthermore, they expressed that the activity required creativity and made for a 
pleasurable learning experience, and did not see it as a hard task that had to be completed. 
When they expressed themselves visually, thoughts and feelings surfaced that would have 
been difficult to express in words. However, it should be noted that the session involving the 
visual expression of thoughts and feelings was not considered suitable for all participants. 
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Growing#in#power#through#the#group#process#
Learning and gaining inspiration from others 
The importance of meeting other young people in the same situation and sharing experiences 
of living with diabetes was highlighted by most of the participants. These factors fostered a 
sense of belonging that could counteract the loneliness of living with diabetes. 
Differences in diabetes self-management led to conversations that resulted in the sharing of 
ideas, knowledge, and advice among participants. In this same manner, participants stated 
that it felt good to hear how others thought, and to understand that their differences were not 
always so significant. Similarly, most of the participants perceived the participation in group 
conversations as worthwhile, inspiring, and encouraging. Several of them described how they 
had learned to make changes in their diabetes self-management and gained insight into the 
importance of taking care of themselves based on the group discussions.  
Some of the adolescents expressed having felt that their human dignity was based on blood 
sugar values before the programme; however, after the intervention, blood sugar levels were 
no longer perceived as a determinant of value. 
On one occasion the group was divided into adolescents and parents (session 3). The 
adolescents found the discussion very fruitful when the group was divided, and described that 
this separation gave them the opportunity to reflect on subjects they did not wish to discuss in 
their parents’ presence, or on issues linked to their parents.  
Parental participation 
The adolescents expressed that parental participation in diabetes self-management was 
important and worthwhile. Further, they believed it was beneficial for parents to share their 
experiences with other parents of children with diabetes. Several adolescents stated that they 
perceived that their parents were calmer and more relaxed after participating in the GSD-Y 
intervention, compared to their demeanour before the intervention. However, the importance 
of having conversations and sharing experiences with one’s parents was also strongly 
emphasized.  
The adolescents stated that their feelings of loneliness decreased after the intervention, and 
that they noticed the same effect on their parents. 
Shared responsibility 
After the intervention, the adolescents found that parental responsibility and support became 
more balanced and transparent. They felt that their parents trusted them more and felt more 
confident in their abilities, and that the effect on the distribution of responsibilities varied; in 
some cases it had increased or decreased while in others it was unchanged. Parental support 
was viewed as relevant, based on the adolescents’ responses. Parents are a source of security, 
advice and support, and the adolescents expressed that they would feel alone without this 
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support. A young person’s need for support and cooperation with his/her parents is of the 
utmost importance. However, the adolescents had difficulty describing the ways their families 
distributed responsibility. 
Deeper understanding between adolescents and parents  
The adolescents expressed that they had gained a better understanding of their parents’ 
anxiety and behaviour after having listened to their thoughts and experiences. They also 
described the benefits of hearing the experiences of the parents of other adolescents. 
Consequently, relationships and communication between adolescents and parents had 
changed, resulting in less nagging and fewer conflicts. The adolescents experienced an 
improved level of understanding from their parents regarding how young people think about 
diabetes. Some of the adolescents described that their diabetes self-management had 
previously been handled in the way their parents wanted, which had led to conflicts. After 
participating in the education programme, however, the adolescents’ autonomy had increased 
and their parents supported this. 
One clear result that emerged was that nagging takes on another dimension once you 
understand the reasons behind it. This understanding also resulted in experiences of fewer 
conflicts.
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7# DISCUSSION#
 
The overall aim of this thesis was to increase the knowledge regarding glycaemic control, 
type of treatment, HRQoL, and a theory-based education among youth with type 1 diabetes. 
The main results initially show an improvement in glycaemic control for patients using CSII 
compared with MDI treatment. GSD-Y in connection with the start of CSII has the potential 
to further improve glycaemic control. Furthermore, GSD-Y increases the readiness to change, 
mitigates experiences of loneliness, and contributes to conscious reflections about self-
management in the group (referent power) together with the group leader (expert power). For 
children and adolescents, it is important to have possibilities to measure HRQoL from the 
perspective of both the youths and their parents, and Check your Health may be useful in 
doing this, in both studies and clinical settings. 
 
7.1# GLYCAEMIC#CONTROL#
There are few studies comparing CSII and MDI for a period of more than one year and using 
analogue insulin for both groups (66, 67). The study by Jakish et al. is consistent with Paper I: 
an improvement in HbA1c was initially identified, but thereafter subsequently deteriorated. 
However, information about type of insulin is not reported in this study (69). It may be of 
interest to consider whether it is the start of CSII, the education, or the fact that the 
participants’ sense of importance due to involvement in a study that has the effect. 
Johannesen et al. gave a brush-up course to all participants before the start of the study. In 
both groups, a non-significant reduction in HbA1c was identified (70). In the same manner, 
Weintrob et al. offered a diabetes course three months before study to motivate participants to 
maintain a strict practice of blood glucose tests and adjust their insulin doses. The HbA1c 
levels at study start were significantly lower than before the course. There were no significant 
improvements in HbA1c during the study (178). At any rate, it should be emphasized that 
regardless of glycaemic control when being treated with CSII, it seems to have a long-term 
effect on the risk of microvascular complications as well as morbidity and mortality in 
cardiovascular disease (64, 65).  
Further, it is important to reflect on the results of the study performed by Johnson et al., in 
which the participants in the whole group sustained their improved HbA1c for the whole 
follow-up period of seven years. Like the study presented in Paper I, this was a ‘real-world’ 
study. The authors describe that the team considered the patients’ suitability for pump therapy 
before a decision was taken; however, it is difficult to say whether this was the reason for the 
sustained improved HbA1c during the long follow-up (72).!!
In Paper I, a gender difference was identified from baseline to the end of the study.!In this 
case, the education cannot be the reason for the difference, since it was the same for 
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everyone.!However, a gender difference is also presented in SWEDIABKIDS (2). In Sweden, 
a gender difference has been identified already at the diagnosis of type 1 diabetes (30). 
Undoubtedly, boys can maintain improved HbA1c longer than girls can. One conclusion we 
can draw from this is that girls and boys, different individuals, may need different types of 
education. Diabetes-related education needs to be more person-centred, which is consistent 
with recommendations by ISPAD (17).  
In line with the above, a multicentre prospective RCT was performed, aimed at evaluating an 
intervention with GSD-Y in groups of adolescents starting CSII and their parents (Paper III). 
We found that the GSD-Y intervention – slightly but not significantly – improved HbA1c; 
however, among those with HbA1c above 63 mmol/mol at inclusion, a significant difference 
was detected between the groups favouring the intervention. Higher HbA1c is a significant 
risk factor for late complications (10, 11), and if an intervention with GSD-Y in connection 
with the start of CSII has the ability to decrease HbA1c and maintain this reduction for more 
than six months, it is a highly promising tool. There have been several studies carried out 
using different psychosocial education methods that have not been able to demonstrate an 
improvement in glycaemic control. The number of visits to the clinic could be a factor that 
affects glycaemic control; however, results from other studies have shown that the number of 
visits does not seem to have significance for glycaemic control (152-158, 162, 163). 
In the study in Paper III the attendance was high, with 73% of participants attending more 
than five of the seven sessions. The CASCADE study involved 28 centres, and the 
intervention consisted of four sessions. Of its included participants only 30% attended all 
sessions in the intervention group, and 53% attended at least one session (154). Our first three 
sessions were held in connection with starting CSII, and the study involved only three centres 
in the same area. Further, the families perceived that starting CSII treatment and education 
were a coherent concept. Families usually experience starting CSII as a positive event, and it 
may be easier to carry out an educational intervention and achieve higher attendance for this 
in connection with other changes, when there already exists a ‘window of opportunity’. It is 
difficult to conclude whether the level of participation had any effect on glycaemic control. 
Unfortunately, sociodemographic data were not collected; therefore, it is not possible to draw 
any conclusions as to whether there was an association between participation and parents’ 
education or family structure. 
While it could be expected that the use of CGM should decrease HbA1c values, the current 
study was not able to show any differences between the use and no use of CGM. One 
explanation for this could be that having high HbA1c was an indication for the use of CGM; 
another could be that those who used CGM had not received the correct support or 
information for its use (82).  
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7.2# HEALTHHRELATED#QUALITY#OF#LIFE#
Viklund et al. showed that the lower the HbA1c, the better the perceived physical health and 
the lower the burden of diabetes (16). Studies measuring HRQoL before and after the start of 
CSII have shown divergent results. Some have shown an increase in HRQoL (179) while 
some have not (178, 180). Other studies have shown correlations between HbA1c and family 
conflicts (106-108, 111, 112, 121, 181, 182). The study in Paper III showed a correlation 
between the difference in HbA1c between baseline and six months, and the difference in 
perceived family conflicts during the same time. There was also a weak correlation between 
HbA1c and family conflicts at six months. The degree of reported family conflicts was rather 
low from the start, which might explain the difference in results compared with other studies. 
At baseline the intervention group perceived more diabetes-related family conflicts, but the 
degree of conflicts decreased in the intervention group whilst it increased in the control 
group; however, the difference at six months was not statistically significant. The GSD 
intervention may have had an impact on the perceived conflicts. 
The degree of perceived diabetes-related conflicts correlated with self-efficacy measured with 
the Swe-DES, which is consistent with the results of previous research (119). The degree of 
self-efficacy seems to be important for achieving recommended glycaemic control (120). The 
intervention group increased their degree of readiness to change, which has previously been 
demonstrated in an empowerment-based education programme for adolescents (153). In the 
study by Husted et al., in which GSD-Y was used individually, the intervention group 
increased their motivation (152).  
The parents’ scoring of their children’s HRQoL in Paper III correlated to the children’s own 
scoring, which was also shown in Paper II. However, the respective scoring of the burden of 
diabetes in Paper III did not correlate between the fathers and the children. The fathers 
perceived the children’s burden as lower than did the children themselves. The opposite was 
found in Paper II, with the parents scoring a higher burden than the children. This was mainly 
noticed in the control group in Paper III; perhaps the fathers in the intervention group had had 
the possibility to learn more about how their children perceived their disease burden. 
 
7.3# PERCEPTIONS#OF#AN#INTERVENTION#WITH#GSDHY#
Our analysis in Paper IV revealed one overall theme to describe adolescents’ perceptions and 
experience of participation in a group-based GSD-Y education. The theme is formulated as 
follows: the importance of expert and referent power in growing awareness of the importance 
of self-management as well as mitigating the loneliness of diabetes.   
In order to, interpret and understand the results in Paper IV, we have used theoretical 
frameworks based on Barrett, and French and Raven (134, 137, 138). Barrett defines power 
in healthcare as ‘the capacity to participate knowingly in change’, including four interrelated 
dimensions – awareness, choices, freedom to act intentionally, and involvement in creating 
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change (134, p. 148). Another dimension of the concept is social power, described by French 
and Raven (1959), who divide it into five forms. Two of the forms – referent and expert 
power – are relevant in the context of this paper. Referent power is defined as the ability of 
some individuals to be a reference for others; they can induce changes in the attitudes, values, 
and decisions of others. Expert power is knowledge resulting from experience or education 
(137, 138).  
The adolescents in Paper IV highlighted the need to meet others in the same situation as 
themselves and to share experiences, which has also been shown in previous studies 
including adolescents and their parents as well as adults (155, 183, 184). Participants 
emphasized that meeting others offers space for reflection and conversations about both 
concrete, everyday issues such as feelings and thoughts, and for taking responsibility for 
one’s diabetes self-management. In our analysis, based upon the theoretical framework, it 
became clear that this is of importance for increasing referent power. A prerequisite for 
creating space regarding referent power in a group is the group leaders’ competence and 
approach, i.e. expert power. This is in line with the GSD method, which highlights the group 
leaders’ role in guiding the participants to reflect in a way that leads to decisions (147). 
Similarly, Lowes et al. describe that good communication with healthcare professionals made 
the visit more valuable (23). 
The adolescents appreciated the reflection worksheets and found them to be a valuable tool in 
conversations. The worksheets highlighted things that otherwise would not have been 
mentioned, and helped in a structured way to deepen the dialogue, leading to clarifications 
about current, real problems experienced when living with diabetes. These results confirm 
that the reflection worksheets are tools that can help in overcoming barriers, as described in 
previous research (146, 151). Lowes et al. have shown that young people feel positive about 
preparing for the visits using pre-formulated questions. They wanted to know what they were 
expected to talk about (23). 
The analysis in Paper IV revealed an additional success factor of the GSD-Y, when 
participants were invited to describe their thoughts about a life with diabetes through words 
or images (Table 3, Session 4). Several of the adolescents experienced visually describing 
things as liberating and creative. In this context, it was a new, positive way to prepare their 
reflections. They felt it was undemanding, and led to new ideas. These results are consistent 
with the study by Piana et al. that described how adolescents experienced describing their 
diabetes in words as stressful, but at the same time found that verbally describing their 
thoughts was liberating and that their self-image and relationships with others and the disease 
benefited from it (185). Buber argues that humans want to create, and that this is a natural 
way to ‘learn’. Visually expressing themselves without expectations creates a natural way for 
humans to express themselves and, because of this, allows them to reflect and learn (144).!!!
A common factor among participants that emerged in our study was a feeling of loneliness, 
likewise difficulty handling diabetes self-management in everyday life. In the analysis, 
according to referent power and Barrett’s theory (134, 137, 138), we interpret that reflections 
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and dialogues – including giving advice to each other – create an arena for making choices 
about what changes they want to make, supporting them in the freedom to choose whether 
they want to do this and, thereafter do it intentionally. In general, the analysis showed that 
these factors were of importance in mitigating loneliness and increasing awareness of self-
management. Consequently, through referent power and expert power, a person may get 
support to become empowered, and create prerequisites for achieving increased self-efficacy. 
Perceived self-efficacy, defined by Bandura, is ‘people’s beliefs about their capabilities to 
produce designated levels of performance that will have influence on events that affect their 
lives. Self-efficacy affects how people feel, think, motivate themselves, and behave’ (186, p. 
71-81).  
Parents were considered to have become more aware of the adolescents’ viewpoints and 
experiences, and the adolescents perceived positive changes in their parents’ demeanour after 
participating in GSD-Y. Previous research has shown that parents are worried about their 
adolescents’ futures and the possibility of developing complications (187). The adolescents 
appreciated parental participation and found it valuable, which led to an increase in their 
mutual respect for and understanding of each other and improved communication, resulting 
in a modified distribution of responsibilities, which reduced nagging and conflicts. 
Adolescents with greater diabetes-related responsibilities and more conflicts take fewer blood 
glucose tests and have poorer blood glucose control (112). Constructive communication 
between parents and adolescents seems to be an important component in diabetes self-
management (95, 188). This emphasizes the importance of parental involvement and 
constructive parental support (95, 96, 122, 188). As a contrast, a study of a group education 
programme not involving parents had no effect on glycaemic control or empowerment 
outcomes (153).  
In conclusion, GSD-Y has, in different ways, facilitated experiences of loneliness and 
contributed to conscious reflection about self-management in the group (referent power) 
together with the group leader (expert power). Overall, this highlights the benefits of group 
education, and the GSD method emphasizes the person-centred approach. 
 
7.4# METHODOLOGICAL#CONSIDERATIONS#
Paper#I#
In Paper I, all children and adolescents who started CSII treatment during the entire study 
period were included, which resulted in a relatively large number of participants. The types of 
insulin for the participants in the control group on MID were: direct-acting insulin analogues 
for meals, and a majority with long-acting analogues once or twice a day. Comparing results 
between studies of similar design can be discussed, as the treatment is not equivalent or clear 
regarding the type of insulin (69, 72). 
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Even though this was not an RCT, which is the gold standard, and power calculations were 
not performed, the study population was 431 individuals and therefore the results are relevant 
for the whole group. However, when divided into different subgroups they were too small for 
any difference to be detected.  
Paper#II#
Check your Health has four domains with only one item each, measuring physical and 
emotional health, social relations, and QoL. The respondents decide how to interpret the 
single item in each domain. Further, in the DCGM-37, there are six to seven items in each 
domain. It could be discussed whether these two highly different ways of design are 
comparable. On the other hand, there are very few measures that have been translated and 
validated for youth with type 1 diabetes in Sweden (14, 15).  
In Paper II the physical domain has the weakest correlation; however, the same was detected 
when psychometric properties were evaluated for Check your Health on adolescents (16). 
When the questionnaire was validated on adults, good consistency was identified; however, 
in that study the physical domain in Check your Health was compared with one item in the 
SF-36 (‘How is your general health today?’), and this item may be closer to the one in Check 
your Health (56). It is unusual for children and adolescents with diabetes to experience major 
physical problems (14, 16). They rarely have long-term complications due to diabetes. 
Therefore, some questions may be perceived as irrelevant if they can run around as they wish, 
or if they sleep well. In Sweden, young persons with type 1 diabetes manage a great deal of 
their diabetes self-management themselves and rarely need help. One reason for the weak 
correlation of convergent validity may be that Check your Health likely measures health 
more generally than the DCGM-37. The results in Paper II are consistent with previous 
research, except regarding emotional health, whereby the children and adolescents in Paper II 
scored higher (16). However, this may be because they were younger in the present study. 
As mentioned, a limitation of this study was the shortage of questionnaires validated and 
translated into Swedish. Therefore, it was difficult to find a suitable questionnaire to analyse 
convergent validity. Further, Check your Health is only available in Swedish and it is 
therefore not possible to make any comparisons with studies from other countries. The test-
retest reliability may have been affected by the circumstances that the questionnaires were 
completed at the hospital and the re-test was completed in the participants’ homes. 
Paper#III#
One of the foremost strengths of this study was the RCT design, which ensures that the two 
groups (intervention and control) are comparable regarding age, sex, and diabetes-related data 
such as duration since diagnosis and HbA1c. As the dropout rate was negligible, the risk of 
selection bias was greatly reduced. The choice of research design creates the prerequisite for 
the outcome to be generalized to young people starting CSII treatment and receiving a GSD-
Y education.  
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However, there are critical considerations that may have affected the results. In general, there 
are pros and cons to clinical studies. A difficulty encountered in this study was that there 
were changes in the diabetes care – e.g., a national project including all clinics working with 
children and adolescents with diabetes resulting in changed treatment goals, increased use of 
carbohydrate counting and CGM – resulting in the recruitment of participants over a long 
period of time, which may have affected the result. Further, there were several who were 
positive to participate in the study, but declined before the randomization. Power calculation 
indicated that each group had to contain at least 37 participants. Due to the mentioned factors 
and the reliability of the result we decided to close the study inclusion in November 2016 
even though we did not reach the desired number of participants. 
In addition, we did not ask the participants about specific events (such as those related to 
school, family, or individual life events, etc.) that occurred during the intervention period that 
could have affected the results, and we did not collect demographic data such as parents’ 
education level or socioeconomic status. 
Major psychological and physiological changes occur during adolescence, which may have 
affected the outcome. On the other hand, the age distribution was similar in both groups, 
which would indicate that these types of changes would be equivalent in the two groups. 
Although we used validated questionnaires, bias might be observed from pre- to post-test, 
simply due to the nature of the instrument. There is also a risk of regression to the mean, 
which means a tendency for participants whose scores lie at either extreme to score nearer the 
mean when measured a second time. While we have collected data on family conflicts from 
the adolescents there is no collected data on this subject from the parents, which might have 
provided additional interesting information for the results. 
Paper#IV#
In Paper IV, as we wanted to explore whether there was a pattern in adolescents’ experiences 
of participation in the intervention, we chose qualitative content analysis (165, 174). One of 
the highlighted advantages of qualitative content analysis is that it is sensitive to the content 
and flexible in design, and is today an established method (189).  
We have strived to achieve trustworthiness (credibility, dependability, confirmability, and 
transferability) by describing the analytical process in detail, providing quotations from the 
interviews (Paper IV), involving several researchers in the analyses, and describing the 
sample and context in as much detail as possible (165, 174). As the study was small-scale, the 
potential transferability of the findings may be limited. However, previous research using the 
GSD model has shown promising results (146, 151).  
While most of the interviews were conducted in close proximity to the intervention – within a 
few months – one participant was interviewed after a year. This could be a weakness, but 
none of the researchers involved in the analyses noted any major differences. The different 
intervals between intervention and interviews may have increased trustworthiness; the results 
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were consistent despite the varying intervals. Further, the parents were not interviewed; if 
they had been, this might have increased the trustworthiness of the results. 
When participants were selected, we used purposeful sampling with maximum variation. The 
interviewed adolescents were distributed equally according to gender, and there was a 
variation in age.  
A weakness was that participants’ demographic data were not collected; this could have been 
interesting to add to the results. Another limitation of the study was that the participants were 
aware of the researchers’ involvement in the intervention, which may have affected the 
results. 
Two researchers conducted the first three interviews. While they got the impression that this 
did not affect the adolescents, having two adults present could have hindered the adolescents 
in expressing their perspectives. None of the researchers who conducted the interviews had a 
close relationship with the adolescents. 
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8# CONCLUSIONS#AND#CLINICAL#IMPLICATIONS#
 
•! Treatment with CSII may initially result in improved HbA1c and a decreased number of 
severe hypoglycaemic events; however, the frequency of ketoacidosis can increase. 
•! The Guided Self-Determination-Young method have the potential to be a useful tool for 
adolescents starting CSII treatment in group together with their parents for improving 
HbA1c, mitigating the loneliness of diabetes, and contributing to conscious reflection 
about self-management.  
•! The instrument Check your Health by proxy is a reliable and valuable tool for 
measuring perceived physical and emotional health, social relations, and general QoL 
and burden of diabetes. This PROM could be valuable to use in future studies, and may 
also be useful in a clinical context as it is not time-consuming to complete and is easy to 
interpret. 
 
9# FUTURE#STUDIES#
 
•! It is of great interest to evaluate whether the positive results of Paper III will remain at the 
12-month follow-up. The final data will be collected at the end of 2017, and will 
thereafter be analysed and published. 
•! Alternative ways to offer education with the GSD-Y would be of great interest, as many 
young persons have difficulty prioritizing hospital visits. Therefore, it would be great 
interest to test the method virtually. 
•! It would be of interest to further investigate the level of empowerment (measured with 
Swe-DES) and its correlation with glycaemic control in youths with type 1 diabetes. 
•! Further studies are needed to investigate factors contributing to loneliness in adolescents 
living with diabetes and explore whether young people with type 1 diabetes feel more 
lonely than young people without diabetes. 
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10#SVENSK#SAMMANFATTNING#
Bakgrund 
För en person med typ 1-diabetes är det en ständig kamp, ett livslångt projekt att uppnå en 
optimal egenvård, acceptabel glukoskontroll, leva ett bra liv och på kort och lång sikt undvika 
komplikationer. Egenvården inkluderar att ta beslut om måltidsdoser, justera höga blodsocker 
och ständigt ha kontroll över glukosnivån. 
Det finns 7310 (2016) barn och ungdomar (0-18 år) med diabetes i Sverige. Behandling med 
insulin ges med insulininjektioner flera gånger per dag eller med insulinpump. Vid 
insulinpumpbehandling tillförs insulinet kontinuerligt, vanligtvis via en plastkanyl som sitter i 
underhudsfettet. För måltider eller när blodsockret ligger för högt programmeras en dos 
manuellt. År 2016 behandlades 60,9 % av barn och ungdomar med typ 1-diabetes i Sverige 
med insulinpump. 
HbA1c är ett sätt att mäta hur glukoskontrollen varit under två till tre månader. Internationella 
rekommendationer för barn och ungdomar är HbA1c <58 mmol/mol. Under de senaste åren 
har rekommendationerna i Sverige sänkts till HbA1c <48 mmol/mol (normalreferens 31–38,6 
mmol/mol). Flera studier visar att höga glukosnivåer under tonåren ökar risken för 
komplikationer senare i livet. Utöver detta finns risk för akuta komplikationer som 
hypoglykemi (lågt blodsocker) och ketoacidos (syraförgiftning), där hypoglykemi är 
vanligast. Hypoglykemier påverkar vardagen och är en begränsande faktor för att nå optimal 
glukoskontroll. Ketoacidos är ett livshotande tillstånd och orsakas av insulinbrist. Orsaken 
kan vara uteblivna insulindoser eller fel som uppstått vid insulinpumpbehandling. 
Trots stora tekniska framsteg inom diabetesbehandlingen, når mindre än en tredjedel av 
ungdomar >12 år med typ 1-diabetes den rekommenderade glukosnivån (HbA1c <48 
mmol/mol). Hos ungdomar med insulinpumpbehandling är uteblivna måltidsdoser en 
anledning till bristande glukoskontroll. Därutöver är diabetesrelaterade konflikter inom 
familjen en känd riskfaktor för höga glukosvärden. Ansvarsfördelningen för 
diabetesegenvården mellan ungdomar och föräldrar är ofta oklar och behöver tydliggöras. 
Föräldramedverkan och konstruktiv kommunikation under tonårstiden ökar sannolikheten att 
den unge med diabetes att uppnå god glukoskontroll.  
Utbildning till barn och ungdomar med typ 1-diabetes är nyckeln till framgång i 
diabetesegenvården. Den bör vara strukturerad, personcentrerad och flexibel. Personcentrerad 
vård framhåller vikten av att lära känna personen bakom patienten och att engagera denne i 
sin egen vård och behandling. 
I patientutbildning med personer som har en kronisk sjukdom är det viktigt att lyfta fram 
personens egen inneboende kraft, ‘power’, definierat som ‘förmågan att medvetet delta i 
förändring’. Två former av power som kan vara av betydelse i patientutbildning är 
empowerment och social power. Inom diabetesvården är den vanligaste definitionen av 
empowerment: ‘Att upptäcka och använda sin inneboende förmåga för att ta kontrollen över 
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sitt liv’ (Funnell och Anderson). Två former av social power är referent power och expert 
power. Referent power är förmågan att vara en referens och ha avgörande betydelse för 
andra, vilket kan medföra förändringar i attityder, värderingar och andra beslut. Expert power 
är kunskap från en person som har erfarenhet eller utbildning. 
Guided Self-Determination (guide till självbestämmande, GSD) är en empowermentbaserad, 
personcentrerad, reflektions och problemlösande utbildningsmetod avsedd att guida patienten 
till självbestämmande och utvecklande av livskunskap för att hantera svårigheter i 
diabetesegenvården. I metoden används arbetsblad och kommunikationsmetoder (spegling, 
aktiv lyssning och värderingsförklaring). GSD är en hjälp för patienten och vårdpersonalen 
att övervinna hinder till empowerment. Metoden finns anpassad för ungdomar (GSD-Y). I en 
studie individuellt med ungdomar och deras föräldrar gav GSD-Y ingen minskning av 
HbA1c. GSD-Y förbättrade dock motivationen till diabetesegenvården och gav ökad 
livskunskap, viket innebar en ny relation till vårdpersonalen och föräldrarna, ökad förmåga 
till att ta beslut och personlig mognad. 
Det övergripande syftet med denna avhandling var att öka kunskapen om glukoskontroll, 
olika typer av diabetesbehandling, hälsorelaterad livskvalitet och en teoribaserad utbildning 
för ungdomar med typ 1-diabetes. För detta genomfördes fyra delstudier 
I studie I undersöktes långsiktig effekt på glukoskontroll, ketoacidos, allvarliga 
hypoglykemiska episoder, insulinbehov och BMI-SDS hos barn och ungdomar med typ 1-
diabetes som startar behandling med insulinpump jämfört med barn och ungdomar som 
behandlas med insulininjektioner. Data samlades in från 216 barn och ungdomar som startat 
insulinpumpbehandling. Dessa matchades för ålder, kön och HbA1c med en kontrollgrupp 
med 215 deltagare som behandlades med insulininjektioner. 
Resultatet visade att efter sex och 12 månader fanns en skillnad mellan grupperna till fördel 
för dem som startat insulinpumpbehandling. När gruppen delades in i kön kunde en skillnad 
ses för både flickor och pojkar efter sex månader, men det var bara för pojkarna en skillnad 
kunde ses efter 12 månader. När gruppen delades in i olika åldersgrupper (<7 år, 7-<12 år och 
>12 år) var det bara efter sex månader en skillnad i HbA1c kunde ses för deltagare 12 år och 
äldre. Antalet ketoacidoser var fler i insulinpumpsgruppen än i injektionsgruppen (2,8 vs. 0,5 
episoder/100 personår). Förekomsten av svåra hypoglykemier var färre i 
insulinpumpsgruppen 3 vs. 6 episoder/100 personår). 
I Studie II testades validiteten (giltigheten, mäter frågeformuläret det som är avsett att mäta) 
och reliabiliteten (tillförlitligheten) hos frågeformuläret ‘Ta tempen på din hälsa’ 
(föräldraversionen) på föräldrar till barn och ungdomar med diabetes. Frågeformulär från 197 
föräldrar och deras barn utvärderades. Reliabiliteten var måttlig till stark. När validiteten 
testades visade resultaten att föräldrarna rapporterade lägre än barnen på känslomässigt 
välbefinnande och sociala relationer. Föräldrarna skattade en högre diabetesbörda på fysisk 
hälsa, känslomässigt välbefinnande och generell livskvalitet än barnen. Tidigare studier har 
   56 
också visat att föräldrar skattar sina barns hälsa och livskvalitet lägre än barnen själva vilket 
stärker validiteten av ‘Ta tempen på din hälsa’ (föräldraversionen).  
I studie III utvärderade om en utbildning med metoden GSD-Y i grupper med tonåringar 
som startar insulinpumpbehandling och deras föräldrar leder till förbättrad glukoskontroll, 
ökad upplevd hälsa och hälsorelaterad livskvalitet, färre diabetesrelaterade familjekonflikter 
och förbättrad tilltro till egen förmåga.  
I studien deltog 71 ungdomar som startade insulinpumpbehandling tillsammans med sina 
föräldrar. De delades in i grupper med tre till fem ungdomar och deras föräldrar i varje grupp. 
Därefter lottades de till att delta i en utbildning med metoden GSD-Y eller till kontrollgrupp 
som följdes enligt ordinarie rutiner. Av dessa hade 48 ungdomar (69 %) HbA1c över 63 
mmol/mol, 23 (62 %) i utbildningsgruppen och 25 (76 %) i kontrollgruppen. 
Utbildningsgruppen träffades för GSD-Y samtal i anslutning till start av 
insulinpumpbehandling (tre tillfällen) och vid fyra tillfällen de första fyra månaderna därefter. 
Före varje GSD-Y samtal fyllde deltagarna i olika reflektionsblad anpassade för varje 
utbildningstillfälle. Dessa användes som samtalsunderlag i utbildningen.  
HbA1c värdet vid sex månader kunde till 45 % förklaras av deltagande i utbildningsgrupp 
(deltagande gav lägre HbA1c) och tilltro till egen förmåga (bättre tilltro till egen förmåga gav 
lägre HbA1c). Bland deltagarna med HbA1c över 63 mmol/mol vid studiestart hade 
utbildningsgruppen ett lägre HbA1c än kontrollgruppen efter sex månader, 57 mmol/mol hos 
utbildningsgruppen jämfört med kontrollgruppens 66 mmol/mol. 
Poängbedömningen av diabetesrelaterade familjekonflikter kan variera mellan 19 (inga 
konflikter) och 57 (högsta grad av konflikter). I denna studie varierade konflikterna mellan 19 
och 37 vid studiestart och 19 och 44 vid 6 månader. Vid studiestart fanns en skillnad mellan 
grupperna med en median på 25 i utbildningsgruppen jämfört med 22 i kontrollgruppen. I 
utbildningsgruppen minskade konflikterna och i kontrollgruppen ökade de, vid sex månader 
kunde ingen statistisk skillnad ses mellan grupperna.  
I denna studie mättes även tilltro till egen förmåga med frågeformuläret Swe-DES. Vid sex 
månader kunde ett samband ses mellan HbA1c-värde och tilltro till egen förmåga. Dessutom 
kunde ett samband ses mellan HbA1c och förmåga att identifiera och lösa problem samt 
mellan HbA1c och förändringsbenägenhet.  
Vid studiestart beskrev utbildningsgruppen en lägre grad av förändringsbenägenhet än 
kontrollgruppen. Efter sex månader hade förändringsbenägenheten ökat i utbildningsgruppen, 
men var oförändrad i kontrollgruppen. 
I studie IV intervjuades 13 ungdomar som deltagit i utbildningsgruppen i studie III.  Syftet 
var att beskriva ungdomars uppfattningar om deltagande i grupputbildning med metoden 
GSD-Y tillsammans med föräldrar i samband med start av insulinpumpbehandling.  
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I resultatet framkom två kategorier – ‘vikten av sammanhang’ och ‘växande power’ genom 
grupprocessen (figur 6 tidigare i avhandlingen). Att träffa andra i samma situation är viktigt; 
det skapar en känsla av tillhörighet och lindrar känslan av ensamhet. Att dela tankar och 
erfarenheter leder till nya idéer och verktyg för att hantera sin diabetes i det dagliga livet. Ett 
övergripande tema som framkom var ‘vikten av expert (gruppledarna) och referent (övriga 
deltagare) “power” för ökad medvetenhet av betydelsen av egenvård, samt för att mildra 
ensamhetskänslan vid diabetes’. 
Deltagarna betonade vikten av gruppledarens roll och uppskattade en positiv och tillåtande 
atmosfär. Arbetsbladen som användes i samtalen var användbara eftersom de ledde till en 
djupare reflektion. De hjälpte till att ta upp frågor som de inte annars skulle ha diskuterat. Vid 
ett tillfälle var syftet att beskriva bilder och tankar om att leva med diabetes. Detta 
uppskattades och beskrevs som värdefullt av deltagarna. När de uttryckte sig med bilder och 
text uppkom tankar och känslor som hade varit svåra att uttrycka verbalt. 
Ungdomarna uttryckte att föräldrarnas delaktighet i diabetesegenvården var viktig och 
värdefull. Dessutom trodde de att det var värdefullt för föräldrarna att dela sina erfarenheter 
med andra föräldrar till barn med diabetes. Flera ungdomar beskrev att de upplevde sina 
föräldrar lugnare och mer avslappnade efter att ha deltagit i utbildningen med GSD-Y.  
Efter utbildningen upplevde ungdomarna att ansvarsfördelningen och föräldrarnas stöd blev 
mer balanserat och transparent. De upplevde att föräldrarna litade på dem vilket ledde till 
ökad tilltro till sin förmåga. Ungdomarna uttryckte att de hade fått bättre förståelse för 
föräldrarnas oro och beteende efter att ha hört deras tankar och upplevelser. 
Relationen och kommunikation mellan ungdomar och föräldrar, förändrades under 
utbildningen, vilket resulterade i mindre tjat och färre konflikter. Ungdomarna upplevde en 
bättre förståelse från sina föräldrar om hur ungdomar tänker om diabetes. Ett tydligt resultat 
som framkom var att tjat får en annan dimension när du förstår orsakerna bakom tjatet. Denna 
förståelse resulterade också i erfarenheter av färre konflikter. 
Sammanfattningsvis har resultaten i denna avhandling visat att behandling med insulinpump 
initialt kan resultera i förbättrat HbA1c. GSD-Y kan vara ett användbart verktyg för 
ungdomar som startar insulinpumpbehandling i grupp tillsammans med sina föräldrar för att 
förbättra HbA1c, mildra ensamhetskänslan vid diabetes och bidra till medveten reflektion om 
egenvården. 
Frågeformuläret ‘Ta tempen på din hälsa’ (föräldraversionen) är tillförlitligt och säkert för att 
mäta upplevd fysisk hälsa, känslomässigt välbefinnande, sociala relationer, generell 
livskvalitet och diabetesbörda. Det kan vara värdefullt att använda i framtida studier och kan 
också vara användbart i ett kliniskt sammanhang eftersom det inte är tidskrävande att fylla i 
och är lätt att tolka. 
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